| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 7.52e-05 | 7 | 262 | 3 | GO:0005004 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.19e-04 | 8 | 262 | 3 | GO:0140945 | |
| GeneOntologyBiologicalProcess | circulatory system development | NCOA6 SP100 ACACB RPS6KA2 MAML1 E2F7 RB1CC1 RYR1 SALL1 AMOT ACAN SEC24B TAL1 DNAH5 NOTCH2 NOTCH3 ROBO4 TBX4 FN1 SYNE1 APC NOX4 PCDHA7 RBM20 ARHGEF15 EPN2 ADGRG6 TGFA RLN2 COL18A1 NCOR2 LBX1 HEY1 ARID2 HGS TLR3 ANKRD17 GAB1 SMAD2 | 5.11e-06 | 1442 | 260 | 39 | GO:0072359 |
| GeneOntologyBiologicalProcess | embryo development | TANC2 NCOA6 E2F7 PDZD7 ZEB2 MAPK8IP3 HIRA OTUD7B HOXA3 XYLT1 SALL1 AMOT SEC24B KMT2A DMBT1 TAL1 NOTCH2 CCSAP TBX4 FN1 TRIOBP CREBBP EPN2 COL18A1 NCOR2 PALS1 KMT2D LATS2 LBX1 HEY1 SH3PXD2A ARID2 UNK UBR3 ANKRD24 GAB1 SMAD2 | 2.70e-05 | 1437 | 260 | 37 | GO:0009790 |
| GeneOntologyBiologicalProcess | heart development | NCOA6 ACACB RPS6KA2 MAML1 RB1CC1 RYR1 SALL1 ACAN SEC24B DNAH5 NOTCH2 FN1 SYNE1 APC NOX4 PCDHA7 RBM20 ADGRG6 NCOR2 LBX1 HEY1 ARID2 GAB1 SMAD2 | 3.45e-05 | 757 | 260 | 24 | GO:0007507 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 PDZD7 ZEB2 MAPK8IP3 NEO1 CDH20 SEC24B AFDN DMD TAL1 NOTCH2 NOTCH3 ROBO4 FN1 SYT3 SYNE1 APC LMTK2 TRIOBP NOX4 MAP7 ADNP CCDC88C COL18A1 LATS2 FARP1 UNK ANKRD24 ZMYM3 EPHA4 EPHA7 EPHA8 | 4.68e-05 | 1194 | 260 | 32 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | ABCA2 RB1CC1 BDKRB1 ZEB2 MAPK8IP3 MAGI2 PTPN13 SIK2 DMD NOS1 PSRC1 IL23R CARD14 NOTCH2 MAPK8IP1 CEP85 FN1 MCPH1 ARHGEF5 TOM1L1 APC NOX4 ADNP TGFA CCDC88C LATS2 HGS TLR3 EIF4G1 SLC4A4 EIF4G3 PPP6R2 INPP5J GAB1 EPHA4 EPHA7 | 4.91e-05 | 1421 | 260 | 36 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | ABCA2 RB1CC1 BDKRB1 ZEB2 MAPK8IP3 MAGI2 PTPN13 SIK2 DMD NOS1 PSRC1 IL23R CARD14 NOTCH2 MAPK8IP1 CEP85 FN1 MCPH1 ARHGEF5 TOM1L1 APC NOX4 ADNP TGFA CCDC88C LATS2 HGS TLR3 EIF4G1 SLC4A4 EIF4G3 PPP6R2 INPP5J GAB1 EPHA4 EPHA7 | 5.06e-05 | 1423 | 260 | 36 | GO:0051174 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | SEPTIN9 RPS6KA2 SH3BP1 ZEB2 ANKRD53 NCAPG UBAP2L SLC35F6 CENATAC TAL1 PSRC1 NPHS1 CHMP4C CCSAP MCPH1 SYT3 ARHGEF5 SYNE1 TOM1L1 APC TRIOBP NOX4 TBC1D25 MORC2 ARHGEF15 KCTD17 TGFA CCDC88C ARID2 SMARCC2 EIF4G3 CROCC SLX4 INPP5J | 8.12e-05 | 1342 | 260 | 34 | GO:0033043 |
| GeneOntologyBiologicalProcess | embryonic organ development | NCOA6 E2F7 PDZD7 HOXA3 SALL1 SEC24B KMT2A TAL1 NOTCH2 TBX4 TRIOBP EPN2 COL18A1 LBX1 HEY1 ARID2 ANKRD24 GAB1 SMAD2 | 9.89e-05 | 561 | 260 | 19 | GO:0048568 |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | RB1CC1 BDKRB1 ZEB2 MAPK8IP3 PTPN13 DMD NOS1 PSRC1 IL23R CARD14 NOTCH2 MAPK8IP1 CEP85 FN1 ARHGEF5 TOM1L1 APC NOX4 ADNP TGFA CCDC88C LATS2 HGS TLR3 EIF4G1 EIF4G3 INPP5J GAB1 EPHA4 EPHA7 | 1.02e-04 | 1133 | 260 | 30 | GO:0001932 |
| GeneOntologyBiologicalProcess | cell junction assembly | DLG5 SH3BP1 MAGI2 PTPN13 PTPRA CDH20 CLDN20 AFDN NPHS1 OCEL1 FN1 PCDHB6 PCDHB3 APC ADNP ARHGEF15 FARP1 EIF4G1 EPHA7 | 1.19e-04 | 569 | 260 | 19 | GO:0034329 |
| GeneOntologyBiologicalProcess | regulation of chromatin organization | 1.41e-04 | 40 | 260 | 5 | GO:1902275 | |
| GeneOntologyCellularComponent | anchoring junction | DLG5 EFS SH3BP1 ERBIN MAGI2 PTPRA CDH20 AMOT CLDN20 AFDN DMD NPHS1 OCEL1 PNN ARHGEF5 APC TRIOBP TNS2 NOX4 CCDC88C PALS1 LMO7 RANGRF SH3PXD2A MDC1 GAB1 EPHA4 | 1.04e-04 | 976 | 262 | 27 | GO:0070161 |
| GeneOntologyCellularComponent | apical junction complex | 1.76e-04 | 158 | 262 | 9 | GO:0043296 | |
| GeneOntologyCellularComponent | tight junction | 3.75e-04 | 139 | 262 | 8 | GO:0070160 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 3.94e-04 | 12 | 262 | 3 | GO:0044666 | |
| MousePheno | abnormal muscle morphology | NCOA6 HIP1 ACACB RPS6KA2 MAML1 HIC2 QRICH1 RB1CC1 RYR1 HOXA3 KMT2A DMD TAL1 DNAH5 NOS1 NOTCH2 NOTCH3 ROBO4 FN1 ADAMTS2 SYNE1 TBC1D25 MORC2 CREBBP RBM20 ADGRG6 TGFA LATS2 LBX1 LMO7 RANGRF SH3PXD2A ARID2 HGS TRAPPC10 ANKRD17 SLC4A4 GAB1 | 2.08e-06 | 1106 | 215 | 38 | MP:0002108 |
| MousePheno | abnormal cardiac muscle tissue morphology | NCOA6 RPS6KA2 HIC2 QRICH1 RB1CC1 DMD TAL1 DNAH5 NOS1 NOTCH2 FN1 TBC1D25 MORC2 CREBBP RBM20 ADGRG6 LATS2 RANGRF SH3PXD2A ARID2 TRAPPC10 ANKRD17 | 6.59e-06 | 489 | 215 | 22 | MP:0010630 |
| MousePheno | abnormal heart development | NCOA6 NR6A1 RYR1 HIRA TAL1 DNAH5 FN1 APC MORC2 CREBBP CEP164 ADGRG6 NCOR2 LBX1 SH3PXD2A HGS ANKRD17 SMAD2 | 1.81e-05 | 372 | 215 | 18 | MP:0000267 |
| MousePheno | embryonic lethality during organogenesis | NCOA6 SEPTIN9 NR6A1 ZEB2 HIRA SALL1 UBE2N AMOT KMT2A AFDN TAL1 NOTCH2 TBX4 FN1 PNN APC MORC2 CREBBP CEP164 ADGRG6 RIF1 KMT2D LATS2 LBX1 ARID2 HGS ANKRD17 CABIN1 GAB1 SMAD2 | 3.03e-05 | 876 | 215 | 30 | MP:0006207 |
| MousePheno | abnormal heart ventricle morphology | NCOA6 RPS6KA2 HIC2 QRICH1 PHF8 RB1CC1 RYR1 OTUD7B HOXA3 SEC24B DMD TAL1 DNAH5 NOS1 PNN MORC2 CREBBP RBM20 ADGRG6 NCOR2 LATS2 LBX1 RANGRF SH3PXD2A ARID2 TRAPPC10 ANKRD17 GAB1 | 3.34e-05 | 793 | 215 | 28 | MP:0005294 |
| MousePheno | abnormal nervous system development | NCOA6 DLG5 NR6A1 ZEB2 MAPK8IP3 HIRA ZC3H11A SALL1 SEC24B AFDN DNAH5 NOS1 NOTCH3 ROBO4 FN1 RNF31 MCPH1 ARHGEF5 TMEM63C APC MORC2 ADNP CREBBP CEP164 ARHGEF15 ADGRG6 COL18A1 LATS2 LBX1 HGS TLR3 TRAPPC10 ANKRD17 SLX4 SMAD2 EPHA4 EPHA7 EPHA8 | 3.90e-05 | 1257 | 215 | 38 | MP:0003861 |
| MousePheno | abnormal cardiovascular development | NCOA6 NR6A1 RB1CC1 RYR1 HIRA HOXA3 AMOT SEC24B TAL1 DNAH5 NOTCH3 ROBO4 TBX4 FN1 PNN APC MORC2 CREBBP CEP164 ARHGEF15 ADGRG6 NCOR2 LBX1 SH3PXD2A ARID2 HGS ANKRD17 SMAD2 | 4.08e-05 | 802 | 215 | 28 | MP:0002925 |
| MousePheno | abnormal myocardium layer morphology | NCOA6 RPS6KA2 HIC2 QRICH1 RB1CC1 DMD NOTCH2 FN1 TBC1D25 MORC2 CREBBP RBM20 ADGRG6 LATS2 RANGRF SH3PXD2A ARID2 ANKRD17 | 7.32e-05 | 414 | 215 | 18 | MP:0005329 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | NCOA6 SEPTIN9 NR6A1 ZEB2 HIRA UBE2N KMT2A AFDN TAL1 NOTCH2 TBX4 FN1 PNN APC MORC2 CREBBP CEP164 ADGRG6 KMT2D LATS2 ARID2 HGS ANKRD17 CABIN1 SMAD2 | 7.60e-05 | 700 | 215 | 25 | MP:0011098 |
| MousePheno | abnormal heart layer morphology | NCOA6 RPS6KA2 HIC2 QRICH1 RB1CC1 DMD NOTCH2 FN1 TBC1D25 MORC2 CREBBP RBM20 ADGRG6 LATS2 RANGRF SH3PXD2A ARID2 ANKRD17 | 9.34e-05 | 422 | 215 | 18 | MP:0010545 |
| MousePheno | abnormal pericardial cavity morphology | 1.60e-04 | 128 | 215 | 9 | MP:0012501 | |
| MousePheno | abnormal fluid regulation | NCOA6 DLG5 RB1CC1 RYR1 HIRA ACAN KMT2A TAL1 NOS1 NOTCH2 NPHS1 ROBO4 TBX4 PNN NT5E TNS2 MORC2 CEP164 ADGRG6 NCOR2 LATS2 SH3PXD2A ARID2 ANKRD17 UNK SLC4A4 GAB1 | 1.70e-04 | 826 | 215 | 27 | MP:0001784 |
| Domain | ENTH_VHS | 2.39e-06 | 29 | 258 | 6 | IPR008942 | |
| Domain | PDZ | DLG5 PDZD7 ERBIN MAGI2 PTPN13 MAST4 AFDN NOS1 CARD14 PALS1 LMO7 | 6.81e-06 | 148 | 258 | 11 | SM00228 |
| Domain | - | DLG5 PDZD7 ERBIN MAGI2 PTPN13 MAST4 AFDN NOS1 CARD14 PALS1 LMO7 | 7.75e-06 | 150 | 258 | 11 | 2.30.42.10 |
| Domain | PDZ | DLG5 PDZD7 ERBIN MAGI2 PTPN13 MAST4 AFDN NOS1 CARD14 PALS1 LMO7 | 8.26e-06 | 151 | 258 | 11 | PS50106 |
| Domain | PDZ | DLG5 PDZD7 ERBIN MAGI2 PTPN13 MAST4 AFDN NOS1 CARD14 PALS1 LMO7 | 8.79e-06 | 152 | 258 | 11 | IPR001478 |
| Domain | fn3 | NEO1 IL23R NPHS1 ROBO4 FN1 COL20A1 IGDCC4 IGSF9B EPHA4 EPHA7 EPHA8 | 1.61e-05 | 162 | 258 | 11 | PF00041 |
| Domain | - | 2.51e-05 | 26 | 258 | 5 | 1.25.40.90 | |
| Domain | FYRC | 2.55e-05 | 5 | 258 | 3 | SM00542 | |
| Domain | FYRN | 2.55e-05 | 5 | 258 | 3 | SM00541 | |
| Domain | FYRN | 2.55e-05 | 5 | 258 | 3 | PF05964 | |
| Domain | FYRC | 2.55e-05 | 5 | 258 | 3 | PF05965 | |
| Domain | FYrich_C | 2.55e-05 | 5 | 258 | 3 | IPR003889 | |
| Domain | FYrich_N | 2.55e-05 | 5 | 258 | 3 | IPR003888 | |
| Domain | FYRC | 2.55e-05 | 5 | 258 | 3 | PS51543 | |
| Domain | FYRN | 2.55e-05 | 5 | 258 | 3 | PS51542 | |
| Domain | PDZ | 2.69e-05 | 141 | 258 | 10 | PF00595 | |
| Domain | FN3 | NEO1 IL23R NPHS1 ROBO4 FN1 COL20A1 IGDCC4 IGSF9B EPHA4 EPHA7 EPHA8 | 5.48e-05 | 185 | 258 | 11 | SM00060 |
| Domain | FN3 | NEO1 IL23R NPHS1 ROBO4 FN1 COL20A1 IGDCC4 IGSF9B EPHA4 EPHA7 EPHA8 | 1.05e-04 | 199 | 258 | 11 | PS50853 |
| Domain | FN3_dom | NEO1 IL23R NPHS1 ROBO4 FN1 COL20A1 IGDCC4 IGSF9B EPHA4 EPHA7 EPHA8 | 1.62e-04 | 209 | 258 | 11 | IPR003961 |
| Domain | ZF_CCHC_HIVEP | 1.90e-04 | 2 | 258 | 2 | PS51811 | |
| Domain | GUANYLATE_KINASE_2 | 2.56e-04 | 23 | 258 | 4 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 2.56e-04 | 23 | 258 | 4 | PS00856 | |
| Domain | Guanylate_kin | 4.19e-04 | 26 | 258 | 4 | PF00625 | |
| Domain | GuKc | 4.19e-04 | 26 | 258 | 4 | SM00072 | |
| Domain | GK/Ca_channel_bsu | 4.19e-04 | 26 | 258 | 4 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 4.19e-04 | 26 | 258 | 4 | IPR008144 | |
| Domain | DUF4599 | 5.23e-04 | 12 | 258 | 3 | PF15371 | |
| Domain | DUF4599 | 5.23e-04 | 12 | 258 | 3 | IPR027970 | |
| Domain | Neuroggenic_mastermind-like_N | 5.65e-04 | 3 | 258 | 2 | IPR019082 | |
| Domain | MamL-1 | 5.65e-04 | 3 | 258 | 2 | PF09596 | |
| Domain | DUF3454 | 5.65e-04 | 3 | 258 | 2 | SM01334 | |
| Domain | DUF3454 | 5.65e-04 | 3 | 258 | 2 | PF11936 | |
| Domain | MamL-1 | 5.65e-04 | 3 | 258 | 2 | SM01275 | |
| Domain | DUF3454_notch | 5.65e-04 | 3 | 258 | 2 | IPR024600 | |
| Domain | Relaxin | 5.65e-04 | 3 | 258 | 2 | IPR022421 | |
| Domain | WW_DOMAIN_1 | 6.77e-04 | 51 | 258 | 5 | PS01159 | |
| Domain | WW_DOMAIN_2 | 6.77e-04 | 51 | 258 | 5 | PS50020 | |
| Domain | WW_dom | 7.40e-04 | 52 | 258 | 5 | IPR001202 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 8.47e-04 | 14 | 258 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 8.47e-04 | 14 | 258 | 3 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 8.47e-04 | 14 | 258 | 3 | IPR001426 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 8.47e-04 | 14 | 258 | 3 | IPR001090 | |
| Domain | Eph_TM | 8.47e-04 | 14 | 258 | 3 | IPR027936 | |
| Domain | EphA2_TM | 8.47e-04 | 14 | 258 | 3 | PF14575 | |
| Domain | EPH_lbd | 8.47e-04 | 14 | 258 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 8.47e-04 | 14 | 258 | 3 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 8.47e-04 | 14 | 258 | 3 | IPR016257 | |
| Domain | EPH_LBD | 8.47e-04 | 14 | 258 | 3 | PS51550 | |
| Domain | NODP | 1.12e-03 | 4 | 258 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.12e-03 | 4 | 258 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.12e-03 | 4 | 258 | 2 | IPR010660 | |
| Domain | NOD | 1.12e-03 | 4 | 258 | 2 | PF06816 | |
| Domain | NOD | 1.12e-03 | 4 | 258 | 2 | SM01338 | |
| Domain | NODP | 1.12e-03 | 4 | 258 | 2 | SM01339 | |
| Domain | Notch | 1.12e-03 | 4 | 258 | 2 | IPR008297 | |
| Domain | Post-SET_dom | 1.28e-03 | 16 | 258 | 3 | IPR003616 | |
| Domain | PostSET | 1.28e-03 | 16 | 258 | 3 | SM00508 | |
| Domain | POST_SET | 1.28e-03 | 16 | 258 | 3 | PS50868 | |
| Domain | SAM | 1.38e-03 | 88 | 258 | 6 | SM00454 | |
| Domain | DUF3504 | 1.85e-03 | 5 | 258 | 2 | IPR021893 | |
| Domain | LNR | 1.85e-03 | 5 | 258 | 2 | PS50258 | |
| Domain | DUF3504 | 1.85e-03 | 5 | 258 | 2 | PF12012 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 3.02e-09 | 12 | 176 | 6 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 3.02e-09 | 12 | 176 | 6 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 5.55e-09 | 13 | 176 | 6 | M47534 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.98e-08 | 28 | 176 | 7 | M6177 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.73e-06 | 47 | 176 | 7 | M7946 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.82e-06 | 20 | 176 | 5 | M27881 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 8.04e-06 | 23 | 176 | 5 | MM14954 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.24e-05 | 25 | 176 | 5 | M27880 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.54e-05 | 13 | 176 | 4 | M47423 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.85e-05 | 27 | 176 | 5 | M39545 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.89e-05 | 45 | 176 | 6 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.15e-05 | 46 | 176 | 6 | MM15971 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.76e-05 | 48 | 176 | 6 | M611 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 3.41e-05 | 161 | 176 | 10 | M39770 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 7.26e-05 | 82 | 176 | 7 | MM15922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 8.22e-05 | 58 | 176 | 6 | M29616 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.09e-04 | 61 | 176 | 6 | M39540 | |
| Pathway | PID_HES_HEY_PATHWAY | 3.18e-04 | 48 | 176 | 5 | M288 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.19e-04 | 74 | 176 | 6 | M616 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 3.50e-04 | 49 | 176 | 5 | M618 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.87e-04 | 12 | 176 | 3 | M27159 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 4.37e-04 | 29 | 176 | 4 | M48076 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS | 5.68e-04 | 31 | 176 | 4 | M27393 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 6.29e-04 | 14 | 176 | 3 | M27808 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 HIVEP1 SEPTIN9 PHF8 ERBIN CTTNBP2NL MEF2D PRDM2 MAPK8IP3 OTUD7B ZC3H11A GSE1 UBAP2L MSL3 KMT2A AFDN UNG ZNF579 NOTCH2 TLK2 PNN MORC2 PHC2 PAPOLG NCOR2 RIF1 KMT2D LMO7 MDC1 EIF4G1 TRAPPC10 ANKRD17 SMARCC2 UNK PCDH7 ZMYM3 | 5.87e-18 | 774 | 267 | 36 | 15302935 |
| Pubmed | NCOA6 HIVEP1 ACACB MAML1 GON4L HIC2 PHF8 ERBIN ZEB2 MEF2D PRDM2 HIRA RNF214 KMT2C SALL1 WIZ GSE1 UBAP2L SEC24B KMT2A RPRD2 TAL1 CEP85 ZBTB33 PNN MAP7 MORC2 ADNP CREBBP RBM20 NCOR2 PALS1 RIF1 KMT2D ARID2 MDC1 HGS EIF4G1 ANKRD17 SMARCC2 UNK R3HDM1 CABIN1 PCDH7 SLX4 ZMYM3 | 1.58e-16 | 1429 | 267 | 46 | 35140242 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 NCOA6 DLG5 DENND4A HIVEP1 TEX2 LSG1 EXPH5 RPS6KA2 ERBIN MEF2D PTPN13 MAST4 AMOT SEC24B SIK2 KMT2A PLEKHA5 AFDN NOTCH2 ARHGEF5 APC LMTK2 PTPN21 MAP7 EPN2 CCDC88C LMO7 SH3PXD2A EIF4G1 ANKRD17 R3HDM1 EIF4G3 PCDH7 GAB1 | 1.06e-15 | 861 | 267 | 35 | 36931259 |
| Pubmed | TANC2 LSG1 RPS6KA2 SH3BP1 ERBIN ZEB2 MAPK8IP3 HIRA MAGI2 WIZ UBE2N UBAP2L PLEKHA5 AFDN NOS1 WNK2 TLK2 MAPK8IP1 SYT3 PRR36 SYNE1 APC TRIOBP ADNP CCDC88C NCOR2 PALS1 FARP1 EIF4G1 ANKRD17 SMARCC2 SLC4A4 CABIN1 PPP6R2 NEURL4 EPHA4 | 5.16e-15 | 963 | 267 | 36 | 28671696 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA6 HIVEP1 ACACB NAB1 MAML1 ZEB2 PRDM2 HIRA KMT2C SALL1 WIZ GSE1 KMT2A CREBBP NCOR2 KMT2D ARID2 MDC1 SMARCC2 SLX4 ZMYM3 | 5.57e-13 | 351 | 267 | 21 | 38297188 |
| Pubmed | NCOA6 DLG5 ABCA2 TEX2 MAML1 HIC2 CTTNBP2NL KMT2C MAST4 AMOT PLEKHA5 RPRD2 CEP126 WNK2 RALGDS UVSSA LMTK2 TRIOBP FASTKD2 ADNP LMO7 MDC1 ANKRD17 UNK MAML2 | 6.29e-13 | 529 | 267 | 25 | 14621295 | |
| Pubmed | SP100 HIVEP1 EXPH5 ERBIN MEF2D KMT2C TSC22D1 PLEKHA5 DMD WNK2 RALGDS SYNE1 TOM1L1 APC CREBBP RIF1 USF3 ARID2 HGS ANKRD17 ANKRD24 SLC4A4 MBD5 GAB1 | 7.33e-13 | 486 | 267 | 24 | 20936779 | |
| Pubmed | NCOA6 PHF8 ERBIN KMT2C ZC3H11A NCAPG PTPN13 WIZ UBAP2L AMOT SEC24B KMT2A PLEKHA5 AFDN RPRD2 CEP85 ZBTB33 PNN ADNP CREBBP PALS1 KMT2D LMO7 ARID2 MDC1 | 1.42e-12 | 549 | 267 | 25 | 38280479 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXR1 SP100 HIVEP1 RBPJL MIER3 HLF E2F7 GON4L HIC2 NR6A1 ZEB2 MEF2D PRDM2 HOXA3 TSC22D1 ZC3H11A SALL1 TOX3 KMT2A TAL1 RC3H2 TBX4 ZBTB33 ADNP HIVEP3 KMT2D USF3 LBX1 HEY1 ZFHX2 SMAD2 | 4.82e-12 | 908 | 267 | 31 | 19274049 |
| Pubmed | DLG5 DENND4A TEX2 LSG1 ERBIN CTTNBP2NL PTPN13 MAST4 SCML1 PLEKHA5 RC3H2 APC ZDBF2 MAP7 UNK GAB1 | 8.71e-12 | 209 | 267 | 16 | 36779422 | |
| Pubmed | DLG5 HIP1 AUP1 LSG1 MAML1 GON4L ERBIN CTTNBP2NL HIRA KMT2C ZC3H11A PTPN13 WIZ SEC24B SLC35F6 KMT2A AFDN ZNF579 BMP2K NT5E SYNE1 APC TRIOBP MAP7 MORC2 CEP164 PHC2 EPN2 COL18A1 RIF1 FARP1 ARID2 MDC1 EIF4G1 ANKRD17 UNK EIF4G3 CROCC ZMYM3 | 2.73e-11 | 1497 | 267 | 39 | 31527615 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXR1 MAML1 HIC2 QRICH1 ZEB2 MEF2D HIRA XYLT1 ZC3H11A NCAPG SALL1 WIZ GSE1 NOTCH2 NOTCH3 ZBTB33 MORC2 ADNP CREBBP NCOR2 RIF1 KMT2D EIF4G1 ANKRD17 SMARCC2 NHEJ1 CABIN1 ZMYM3 SMAD2 | 3.05e-11 | 857 | 267 | 29 | 25609649 |
| Pubmed | TANC2 DENND4A ACACB CTTNBP2NL PTPN13 AMOT PLEKHA5 AFDN NOTCH2 CEP85 APC CCDC88C PALS1 LATS2 LMO7 SH3PXD2A HGS TRAPPC10 UNK R3HDM1 PPP6R2 | 5.09e-11 | 446 | 267 | 21 | 24255178 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SEPTIN9 RPS6KA2 COG3 ERBIN MAPK8IP3 KMT2C TSC22D1 ZC3H11A PTPN13 UBAP2L TOX3 RPRD2 CENATAC WNK2 NOTCH2 NOTCH3 MCPH1 UVSSA TOM1L1 TMEM63C TRIOBP CREBBP ADGRG6 HIVEP3 COL18A1 NCOR2 PTPDC1 USF3 LATS2 SH3PXD2A FARP1 ZFHX2 ANKRD17 ANKRD24 IGSF9B EIF4G3 CROCC MBD5 | 9.13e-11 | 1489 | 267 | 38 | 28611215 |
| Pubmed | HIVEP1 ACACB RB1CC1 ZEB2 PRDM2 PTPN13 SALL1 WIZ GSE1 AMOT PLEKHA5 ZBTB33 APC ZDBF2 ADNP RBM20 NCOR2 KMT2D ANKRD17 ZMYM3 | 1.12e-10 | 418 | 267 | 20 | 34709266 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SP100 SEPTIN9 NAB1 QRICH1 MCM10 CTTNBP2NL MEF2D HIRA ZC3H11A SALL1 UBAP2L SEC24B TLK2 ZBTB33 ADNP CREBBP PAPOLG NCOR2 EIF4G1 SLX4 | 3.23e-10 | 444 | 267 | 20 | 34795231 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | HIVEP1 MAML1 E2F7 GON4L ZEB2 PRDM2 KMT2C SALL1 WIZ RC3H2 APC CREBBP RBM20 NCOR2 KMT2D RANGRF ARID2 SMARCC2 ZNF292 | 3.45e-10 | 398 | 267 | 19 | 35016035 |
| Pubmed | NCOA6 HIVEP1 MAML1 MEF2D HIRA WIZ GSE1 KMT2A RPRD2 ZBTB33 PNN U2SURP CREBBP KMT2D MDC1 SMARCC2 | 3.55e-10 | 268 | 267 | 16 | 33640491 | |
| Pubmed | ACACB AUP1 LSG1 MAML1 MCM10 ERBIN OTUD7B NEO1 ZC3H11A PTPN13 WIZ AMOT SEC24B INSM2 AFDN NOTCH2 ZBTB33 FN1 BMP2K APC PODXL2 RIF1 TENM3 EIF4G3 PCDH7 GAB1 | 4.31e-10 | 777 | 267 | 26 | 35844135 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | LSG1 SEPTIN9 HIRA RNF214 PTPN13 WIZ UBAP2L AMOT TLK2 RC3H2 CEP85 BMP2K APC TRIOBP MORC2 LMO7 SH3PXD2A FARP1 EIF4G1 ANKRD17 UNK R3HDM1 KIF18B EIF4G3 ZNF292 | 5.01e-10 | 724 | 267 | 25 | 36232890 |
| Pubmed | ABCA2 HIC2 PHF8 MAPK8IP3 AMOT LMTK2 TNS2 CEP164 EPN2 ZFHX2 IGSF9B | 5.28e-10 | 104 | 267 | 11 | 10470851 | |
| Pubmed | NCOA6 HIVEP1 AUP1 EXPH5 QRICH1 ERBIN ZEB2 MAST4 UBE2N AFDN NOTCH2 TBX4 FN1 ARHGAP9 CREBBP EPN2 NCOR2 KMT2D TENM3 HEY1 EIF4G1 SMAD2 | 1.46e-09 | 591 | 267 | 22 | 15231748 | |
| Pubmed | PHF8 RB1CC1 ERBIN NCAPG PTPN13 PTPRA WIZ GSE1 SEC24B UNG DMD PMS2 CEP85 LMTK2 TRIOBP TNS2 PTPN21 RBM20 NCOR2 PTPDC1 RIF1 KMT2D FARP1 HGS UBR3 PPP6R2 PCDH7 NEURL4 GAB1 | 3.20e-09 | 1049 | 267 | 29 | 27880917 | |
| Pubmed | FOXR1 HIVEP1 PDZD7 QRICH1 MEF2D KMT2C UBAP2L WNK2 TLK2 SYNE1 SYBU RIF1 NEURL4 ZNF292 | 4.22e-09 | 233 | 267 | 14 | 37704626 | |
| Pubmed | TANC2 NCOA6 HIVEP1 ACACB AUP1 MAML1 TMEM200A RYR1 SALL1 GSE1 UBE2N FER1L5 ROBO4 TBX4 TBC1D25 ZDBF2 CREBBP NCOR2 KMT2D ARID2 ANKRD17 SMARCC2 | 5.89e-09 | 638 | 267 | 22 | 31182584 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DLG5 HIVEP1 MAML1 E2F7 SALL1 GSE1 CEP85 APC ZDBF2 MAP7 CREBBP RBM20 PAPOLG NCOR2 LMO7 ARID2 UNK PPP6R2 SLX4 ZMYM3 GAB1 | 7.21e-09 | 588 | 267 | 21 | 38580884 |
| Pubmed | TANC2 EXPH5 TMEM200A TSC22D1 CC2D1B MORC2 RALGAPA2 ARHGEF15 EPN2 HIVEP3 CCDC88C USF3 ARID2 UBR3 ANKRD24 MBD5 PPP6R2 NEURL4 SLX4 | 1.15e-08 | 493 | 267 | 19 | 15368895 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HIVEP1 MCM10 PHF8 ZEB2 PRDM2 HIRA WIZ KMT2A UNG ARHGEF5 MORC2 ADNP PAPOLG RIF1 ARID2 MDC1 SMARCC2 KIF18B CABIN1 ZMYM3 ZNF292 | 1.29e-08 | 608 | 267 | 21 | 36089195 |
| Pubmed | SEPTIN9 CTTNBP2NL MEF2D ZC3H11A UBAP2L PLEKHA5 AFDN RPRD2 ZNF579 PSRC1 PMS2 PNN APC MAP7 MORC2 RIF1 LMO7 EIF4G1 EIF4G3 | 1.58e-08 | 503 | 267 | 19 | 16964243 | |
| Pubmed | TANC2 HDAC11 SEPTIN9 ERBIN MAPK8IP3 MAGI2 PTPRA UBAP2L AMOT KMT2A PLEKHA5 AFDN DMD NOS1 MTUS2 WNK2 MAPK8IP1 FN1 SYT3 PRR36 SYNE1 APC MAP7 EPN2 LMO7 FARP1 EIF4G1 TRAPPC10 SMARCC2 SLC4A4 EIF4G3 CROCC PPP6R2 | 2.08e-08 | 1431 | 267 | 33 | 37142655 | |
| Pubmed | NCOA6 HIC2 PHF8 ERBIN KMT2C AMOT SIK2 PLEKHA5 RPRD2 SYNE1 TRIOBP ARHGEF15 LMO7 | 2.42e-08 | 225 | 267 | 13 | 12168954 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 NCOA6 HIP1 ABCA2 RPS6KA2 MAML1 RYR1 MAPK8IP3 HIRA KMT2C ZC3H11A WIZ TP53I13 ZNF579 WNK2 NOTCH2 LMTK2 TBC1D25 RALGAPA2 PHC2 HIVEP3 CCDC88C NCOR2 KMT2D LATS2 EIF4G1 MBD5 CABIN1 | 3.85e-08 | 1105 | 267 | 28 | 35748872 |
| Pubmed | DENND4A LSG1 GON4L GSE1 SIK2 KMT2A PLEKHA5 AFDN RALGDS RC3H2 CEP85 RNF31 ARHGEF5 APC CC2D1B MORC2 RBM20 ZXDB PALS1 ANKRD17 PPP6R2 | 4.01e-08 | 650 | 267 | 21 | 38777146 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | HIP1 TEX2 SEPTIN9 QRICH1 ERBIN UBE2N USP32 PLEKHA5 NOTCH2 RALGDS CEP85 MAP7 EPN2 NCOR2 RIF1 TENM3 ARID2 NHEJ1 MBD5 | 4.31e-08 | 536 | 267 | 19 | 15840001 |
| Pubmed | HIP1 TEX2 SEPTIN9 QRICH1 ERBIN UBE2N USP32 PLEKHA5 NOTCH2 RALGDS CEP85 MAP7 EPN2 NCOR2 RIF1 TENM3 ARID2 NHEJ1 MBD5 | 4.57e-08 | 538 | 267 | 19 | 10512203 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 ACACB OTUD7B SALL1 WNK2 ARHGEF5 ADNP NCOR2 USF3 ARID2 MDC1 UNK IGSF9B MAML2 EIF4G3 NEURL4 GAB1 | 4.78e-08 | 430 | 267 | 17 | 35044719 |
| Pubmed | 5.03e-08 | 6 | 267 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 5.03e-08 | 6 | 267 | 4 | 25930072 | |
| Pubmed | 7.93e-08 | 29 | 267 | 6 | 36800290 | ||
| Pubmed | DLG5 EXPH5 SEPTIN9 ERBIN PTPN13 AMOT SEC24B PLEKHA5 PNN APC LATS2 HGS R3HDM1 | 1.50e-07 | 263 | 267 | 13 | 34702444 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | ACACB ERBIN GSE1 RPRD2 NOTCH2 NOTCH3 CEP85 NCOR2 LATS2 R3HDM1 CROCC | 1.67e-07 | 180 | 267 | 11 | 35198878 |
| Pubmed | ACACB ERBIN PTPN13 PLEKHA5 DMD NOTCH2 TRIOBP RALGAPA2 EPN2 PALS1 TENM3 HGS PCDH7 GAB1 SMAD2 EPHA4 | 2.04e-07 | 421 | 267 | 16 | 36976175 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | DLG5 ZEB2 MEF2D ZC3H11A SEC24B RPRD2 NOTCH2 CEP85 U2SURP NCOR2 KMT2D | 2.08e-07 | 184 | 267 | 11 | 32908313 |
| Pubmed | ABCA2 QRICH1 ZEB2 MAPK8IP3 MAGI2 PTPN13 PTPRA WIZ USP32 AFDN MTUS2 MAPK8IP1 PMS2 CEP85 FN1 SYNE1 APC TRIOBP CREBBP HEY1 LMO7 EIF4G1 ANKRD24 R3HDM1 EIF4G3 CABIN1 SLX4 SMAD2 ZNF292 | 2.50e-07 | 1285 | 267 | 29 | 35914814 | |
| Pubmed | 4.15e-07 | 9 | 267 | 4 | 12370315 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 HIVEP1 SEPTIN9 MEF2D ZC3H11A SALL1 WIZ UBAP2L KMT2A AFDN RPRD2 ZBTB33 PNN U2SURP ZDBF2 ADNP NCOR2 RIF1 ARID2 MDC1 EIF4G1 SMARCC2 KIF18B SLX4 | 4.33e-07 | 954 | 267 | 24 | 36373674 |
| Pubmed | 4.47e-07 | 3 | 267 | 3 | 23932714 | ||
| Pubmed | NCOA6 HIVEP1 SEPTIN9 NAB1 MAML1 QRICH1 ZEB2 MEF2D PRDM2 KMT2C ZC3H11A WIZ GSE1 KMT2A UNG TLK2 U2SURP MORC2 ADNP CREBBP NCOR2 KMT2D ARID2 SMARCC2 ZMYM3 ZNF292 | 4.82e-07 | 1103 | 267 | 26 | 34189442 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | EXPH5 RYR1 PRDM2 KMT2C KMT2A DNAH5 MORC2 PAPOLG CCDC88C TLR3 ANKRD17 | 7.08e-07 | 208 | 267 | 11 | 33230847 |
| Pubmed | SEPTIN9 GON4L PHF8 ERBIN ZEB2 MAGI2 ZC3H11A GSE1 UBAP2L SYNE1 IGDCC4 TENM3 R3HDM1 CROCC ZMYM3 | 7.23e-07 | 407 | 267 | 15 | 12693553 | |
| Pubmed | DLG5 GON4L MCM10 ERBIN HIRA CDAN1 NCAPG UBAP2L AMOT MSL3 KMT2A UNG PMS2 MAP7 MORC2 CREBBP PHC2 KIF18B CABIN1 | 7.29e-07 | 645 | 267 | 19 | 25281560 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | SEPTIN9 PTPN13 PTPRA UBE2N ADAMTS15 NOTCH3 SYNE1 CC2D1B NCOR2 RIF1 | 7.79e-07 | 168 | 267 | 10 | 30631154 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | RB1CC1 MAGI2 ZC3H11A PTPRA RPRD2 NOTCH2 NOTCH3 RC3H2 PNN TENM3 MDC1 EPHA4 EPHA7 EPHA8 | 8.48e-07 | 358 | 267 | 14 | 32460013 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TANC2 TEX2 LSG1 SEPTIN9 SH3BP1 CDAN1 UBAP2L MTUS2 FN1 SYT3 APC MORC2 NCOR2 UNK IGSF9B INPP5J | 1.00e-06 | 475 | 267 | 16 | 31040226 |
| Pubmed | 1.07e-06 | 11 | 267 | 4 | 18003620 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SEPTIN9 HIC2 PHF8 ZNF831 QRICH2 CTTNBP2NL RYR1 PRDM2 KMT2C CDH20 WIZ GSE1 UBE2N AMOT ADAMTS15 FN1 MCPH1 ARHGAP9 TLR3 IGSF9B | 1.29e-06 | 736 | 267 | 20 | 29676528 |
| Pubmed | MAML1 MCM10 PHF8 SALL1 WIZ RPRD2 TLK2 MORC2 ADNP CREBBP SLX4 | 1.34e-06 | 222 | 267 | 11 | 37071664 | |
| Pubmed | 1.38e-06 | 103 | 267 | 8 | 10819331 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | NCOA6 HIVEP1 KMT2C WIZ GSE1 SCML1 BEND7 KMT2A RC3H2 ADNP PHC2 KMT2D EIF4G1 MBD5 ZMYM3 ZNF292 | 1.71e-06 | 495 | 267 | 16 | 27705803 |
| Pubmed | iNOS is not responsible for RyR1Â S-nitrosylation in mdx mice with truncated dystrophin. | 1.78e-06 | 4 | 267 | 3 | 32693782 | |
| Pubmed | 1.78e-06 | 4 | 267 | 3 | 28398509 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 1.78e-06 | 4 | 267 | 3 | 23129768 | |
| Pubmed | 1.78e-06 | 4 | 267 | 3 | 21414300 | ||
| Pubmed | 1.78e-06 | 4 | 267 | 3 | 24081332 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | AUP1 EXPH5 ERBIN NEO1 PTPRA USP32 PLEKHA5 NOTCH2 RALGAPA2 EPN2 PALS1 LATS2 FARP1 PCDH7 GAB1 EPHA4 EPHA7 | 2.34e-06 | 569 | 267 | 17 | 30639242 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NCOA6 PHF8 ERBIN HIRA WIZ GSE1 KMT2A PMS2 ADNP RIF1 KMT2D MDC1 SMARCC2 | 2.77e-06 | 341 | 267 | 13 | 32971831 |
| Pubmed | DLG5 AUP1 LSG1 SEPTIN9 ERBIN PTPN13 UBAP2L SEC24B PLEKHA5 AFDN ZBTB33 APC CC2D1B HGS EIF4G1 ANKRD17 EIF4G3 PCDH7 GAB1 | 2.86e-06 | 708 | 267 | 19 | 39231216 | |
| Pubmed | TANC2 ACACB TEX2 SEPTIN9 ERBIN MAPK8IP3 MAGI2 NEO1 UBE2N UBAP2L AFDN NOS1 WNK2 MAPK8IP1 U2SURP APC LMTK2 TRIOBP ZDBF2 FARP1 SMARCC2 UBR3 SLC4A4 EIF4G3 PPP6R2 | 2.88e-06 | 1139 | 267 | 25 | 36417873 | |
| Pubmed | 2.92e-06 | 152 | 267 | 9 | 38360978 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA6 AUP1 LSG1 MAML1 QRICH1 MEF2D KMT2C GSE1 CEP85 CREBBP RBM20 NCOR2 RIF1 KMT2D ANKRD17 | 3.01e-06 | 457 | 267 | 15 | 32344865 |
| Pubmed | 3.20e-06 | 14 | 267 | 4 | 12482968 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | HIVEP1 E2F7 HIC2 GSE1 MSL3 UNG DMBT1 PSRC1 TLK2 CCSAP OCEL1 BMP2K TBC1D25 MAP7 PTPDC1 RIF1 EIF4G1 TRAPPC10 EIF4G3 NEURL4 GAB1 MSLN | 3.30e-06 | 925 | 267 | 22 | 28986522 |
| Pubmed | 3.67e-06 | 83 | 267 | 7 | 28794006 | ||
| Pubmed | 4.34e-06 | 15 | 267 | 4 | 17194759 | ||
| Pubmed | 4.42e-06 | 5 | 267 | 3 | 21124806 | ||
| Pubmed | 4.42e-06 | 5 | 267 | 3 | 11101851 | ||
| Pubmed | The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways. | 4.42e-06 | 5 | 267 | 3 | 28747678 | |
| Pubmed | 4.42e-06 | 5 | 267 | 3 | 22932783 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | SP100 DENND4A RBPJL NAB1 HLF MAML1 ZEB2 ANKRD53 HOXA3 TOX3 INSM2 TAL1 TBX4 ZBTB33 APC CREBBP PAPOLG NCOR2 ANKRD33 SMAD2 ZNF292 | 5.01e-06 | 877 | 267 | 21 | 20211142 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | AUP1 LSG1 SEPTIN9 MCM10 PHF8 ERBIN HIRA ZC3H11A NCAPG SEC24B PLEKHA5 AFDN FN1 RNF31 PNN U2SURP FASTKD2 ADNP CREBBP NCOR2 RIF1 MDC1 EIF4G1 ANKRD17 SMARCC2 KIF18B ZMYM3 | 6.56e-06 | 1353 | 267 | 27 | 29467282 |
| Pubmed | OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. | 6.79e-06 | 91 | 267 | 7 | 30472188 | |
| Pubmed | 7.43e-06 | 129 | 267 | 8 | 23022380 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | HIVEP1 EFS MAPK8IP3 UBAP2L BEND7 RPRD2 MTUS2 NOTCH2 NOTCH3 FN1 TRIOBP PHC2 HGS SMARCC2 ANKRD24 R3HDM1 | 8.15e-06 | 560 | 267 | 16 | 21653829 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACB EXPH5 SEPTIN9 KMT2C USP32 KMT2A PLEKHA5 UNG FN1 U2SURP PCDHB6 MORC2 LMO7 ARID2 ZNF292 | 8.23e-06 | 497 | 267 | 15 | 36774506 |
| Pubmed | 8.80e-06 | 6 | 267 | 3 | 9111338 | ||
| Pubmed | Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. | 8.80e-06 | 6 | 267 | 3 | 17021013 | |
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 8.80e-06 | 6 | 267 | 3 | 15019995 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 9.55e-06 | 18 | 267 | 4 | 35503090 | |
| Pubmed | 9.55e-06 | 18 | 267 | 4 | 15689374 | ||
| Pubmed | UBAP2L AMOT SEC24B PNN MAP7 PALS1 LMO7 EIF4G1 SMARCC2 R3HDM1 PCDH7 | 1.00e-05 | 274 | 267 | 11 | 34244482 | |
| Pubmed | 1.20e-05 | 19 | 267 | 4 | 20335360 | ||
| Pubmed | ACACB AUP1 TEX2 LSG1 MCM10 ERBIN MEF2D PTPN13 WIZ AMOT SEC24B PLEKHA5 UNG PSRC1 NOTCH2 CEP85 BMP2K PHC2 COL18A1 HEY1 UNK R3HDM1 | 1.25e-05 | 1007 | 267 | 22 | 34597346 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ACACB LSG1 SEPTIN9 ERBIN ZC3H11A PTPN13 WIZ GSE1 UBAP2L SEC24B KMT2A RPRD2 ZBTB33 PNN U2SURP ADNP RIF1 ARID2 ANKRD17 EIF4G3 PPP6R2 | 1.29e-05 | 934 | 267 | 21 | 33916271 |
| Pubmed | 1.35e-05 | 101 | 267 | 7 | 10997877 | ||
| Pubmed | 1.49e-05 | 234 | 267 | 10 | 36243803 | ||
| Pubmed | Nox4 - RyR1 - Nox2: Regulators of micro-domain signaling in skeletal muscle. | 1.53e-05 | 7 | 267 | 3 | 32506037 | |
| Pubmed | 1.53e-05 | 7 | 267 | 3 | 36598580 | ||
| Pubmed | 1.53e-05 | 7 | 267 | 3 | 19556342 | ||
| Pubmed | TANC2 SP100 LSG1 HIC2 PHF8 WIZ GSE1 SCML1 ZNF579 NOTCH2 ZBTB33 RNF31 MAP7 RALGAPA2 CREBBP ELL3 NCOR2 LBX1 ARID2 ANKRD17 SMARCC2 KIF18B ZMYM3 | 1.98e-05 | 1116 | 267 | 23 | 31753913 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 2.23e-05 | 22 | 267 | 4 | 26886794 | |
| Interaction | YWHAH interactions | TANC2 NCOA6 DLG5 ABCA2 DENND4A HIVEP1 TEX2 LSG1 EXPH5 RB1CC1 ERBIN MEF2D PYHIN1 PTPN13 MAST4 AMOT SEC24B SIK2 KMT2A PLEKHA5 AFDN WNK2 NOTCH2 FN1 PNN ARHGEF5 APC LMTK2 TNS2 TBC1D25 PTPN21 MAP7 CREBBP EPN2 CCDC88C PTPDC1 LATS2 LMO7 SH3PXD2A EIF4G1 TRAPPC10 ANKRD17 R3HDM1 EIF4G3 GAB1 | 6.13e-12 | 1102 | 261 | 45 | int:YWHAH |
| Interaction | YWHAG interactions | TANC2 NCOA6 DLG5 DENND4A HIVEP1 EXPH5 RB1CC1 ERBIN MEF2D PYHIN1 PTPN13 MAST4 AMOT SEC24B SIK2 KMT2A PLEKHA5 AFDN NOTCH2 CHMP4C RC3H2 ZBTB33 FN1 RNF31 PNN ARHGEF5 APC LMTK2 TNS2 PTPN21 MAP7 EPN2 CCDC88C PTPDC1 LATS2 LMO7 SH3PXD2A EIF4G1 TRAPPC10 ANKRD17 UNK R3HDM1 EIF4G3 PCDH7 ZMYM3 GAB1 | 1.09e-10 | 1248 | 261 | 46 | int:YWHAG |
| Interaction | SOX7 interactions | MAML1 ZEB2 KMT2C SALL1 WIZ CREBBP RBM20 NCOR2 KMT2D ARID2 SMARCC2 ZNF292 | 6.42e-10 | 82 | 261 | 12 | int:SOX7 |
| Interaction | ASF1A interactions | NCOA6 HIVEP1 MEF2D PRDM2 HIRA CDAN1 WIZ GSE1 MSL3 KMT2A TLK2 NCOR2 RIF1 KMT2D ARID2 MDC1 SMARCC2 KIF18B CABIN1 | 6.82e-10 | 249 | 261 | 19 | int:ASF1A |
| Interaction | SMG7 interactions | NCOA6 HIVEP1 MAML1 MEF2D RNF214 SALL1 GSE1 UBAP2L AMOT RPRD2 RC3H2 CEP85 UVSSA ZDBF2 CREBBP RBM20 NCOR2 KMT2D ANKRD17 UNK R3HDM1 | 1.25e-09 | 319 | 261 | 21 | int:SMG7 |
| Interaction | HNF4A interactions | NCOA6 HIVEP1 ZEB2 HIRA KMT2C WIZ GSE1 DMD MORC2 ADNP CREBBP NCOR2 KMT2D ARID2 SMARCC2 CABIN1 SLX4 ZMYM3 SMAD2 | 3.57e-09 | 275 | 261 | 19 | int:HNF4A |
| Interaction | WWTR1 interactions | NCOA6 ERBIN NCAPG PTPN13 WIZ AMOT SEC24B KMT2A PLEKHA5 AFDN RPRD2 CEP85 ZBTB33 PNN ADNP CREBBP PALS1 KMT2D LATS2 LMO7 ARID2 SMAD2 | 3.56e-08 | 422 | 261 | 22 | int:WWTR1 |
| Interaction | BAG2 interactions | HDAC11 NCOA6 TEX2 EXPH5 PIWIL1 QRICH1 ERBIN MEF2D HIRA RNF214 WIZ AMOT SIK2 RPRD2 NOTCH3 CHMP4C RC3H2 FN1 RNF31 ADNP CREBBP SLC5A5 LATS2 MDC1 HGS R3HDM1 EIF4G3 | 4.38e-08 | 622 | 261 | 27 | int:BAG2 |
| Interaction | FEV interactions | NCOA6 HIVEP1 MAML1 HIC2 ZEB2 KMT2C SALL1 WIZ GSE1 KMT2A CREBBP NCOR2 KMT2D ARID2 ZMYM3 | 6.83e-08 | 203 | 261 | 15 | int:FEV |
| Interaction | AFDN interactions | DLG5 ERBIN PTPN13 KMT2A PLEKHA5 AFDN MTUS2 NOTCH2 RALGDS FN1 APC TBC1D25 CCDC88C LATS2 SH3PXD2A PCDH7 GAB1 SMAD2 EPHA7 | 7.77e-08 | 333 | 261 | 19 | int:AFDN |
| Interaction | YWHAB interactions | TANC2 DLG5 DENND4A HIVEP1 EXPH5 RB1CC1 ERBIN PTPN13 MAST4 AMOT USP32 SIK2 KMT2A PLEKHA5 AFDN CHMP4C RC3H2 FN1 ARHGEF5 APC TNS2 PTPN21 MAP7 EPN2 CCDC88C PTPDC1 LMO7 SH3PXD2A HGS EIF4G1 TRAPPC10 ANKRD17 UNK R3HDM1 GAB1 | 1.23e-07 | 1014 | 261 | 35 | int:YWHAB |
| Interaction | TNIK interactions | TANC2 LSG1 CTTNBP2NL ZEB2 HIRA MAGI2 WIZ GSE1 PLEKHA5 NOS1 TLK2 SYNE1 APC ADNP NCOR2 PALS1 SMARCC2 CABIN1 NEURL4 EPHA7 | 1.36e-07 | 381 | 261 | 20 | int:TNIK |
| Interaction | NUP43 interactions | NCOA6 HIVEP1 ACACB AVPR2 GON4L PHF8 PRDM2 GSE1 TOX3 KMT2A TBX4 PNN APC ZDBF2 MORC2 NCOR2 RIF1 KMT2D ARID2 MDC1 EIF4G1 EIF4G3 PPP6R2 SLX4 ZMYM3 ZNF292 | 1.81e-07 | 625 | 261 | 26 | int:NUP43 |
| Interaction | GSK3A interactions | DLG5 DENND4A ACACB TEX2 LSG1 ZC3H6 ERBIN CTTNBP2NL PTPN13 MAST4 SCML1 PLEKHA5 RC3H2 PNN U2SURP APC ZDBF2 MAP7 UNK SLX4 GAB1 SMAD2 | 1.86e-07 | 464 | 261 | 22 | int:GSK3A |
| Interaction | EPB41L4A interactions | DLG5 ERBIN PTPN13 MSL3 PLEKHA5 NOTCH2 APC TNS2 PALS1 FARP1 PCDH7 GAB1 | 2.91e-07 | 140 | 261 | 12 | int:EPB41L4A |
| Interaction | TBXT interactions | NCOA6 HIVEP1 MAML1 ZEB2 KMT2C WIZ GSE1 CREBBP NCOR2 KMT2D SMARCC2 | 3.30e-07 | 116 | 261 | 11 | int:TBXT |
| Interaction | GATA2 interactions | NCOA6 HIVEP1 ZEB2 KMT2C SALL1 WIZ GSE1 TAL1 CREBBP NCOR2 KMT2D ARID2 TRAPPC10 SMARCC2 | 3.44e-07 | 199 | 261 | 14 | int:GATA2 |
| Interaction | EGR2 interactions | NCOA6 HIVEP1 NAB1 MAML1 ZEB2 HIRA KMT2C WIZ KMT2A CREBBP NCOR2 KMT2D ARID2 | 3.74e-07 | 171 | 261 | 13 | int:EGR2 |
| Interaction | SP7 interactions | NCOA6 HIVEP1 MAML1 ZEB2 MEF2D KMT2C WIZ GSE1 RPRD2 PNN CREBBP RBM20 NCOR2 KMT2D ARID2 SMARCC2 PCDH7 | 5.07e-07 | 304 | 261 | 17 | int:SP7 |
| Interaction | LHX3 interactions | HIVEP1 QRICH1 ZEB2 MEF2D HIRA KMT2C SALL1 GSE1 DMD CREBBP NCOR2 KMT2D ARID2 | 9.20e-07 | 185 | 261 | 13 | int:LHX3 |
| Interaction | HDAC1 interactions | HIVEP1 ACACB MIER3 GON4L RB1CC1 ZEB2 MEF2D NCAPG PTPN13 SALL1 WIZ GSE1 AMOT KMT2A PLEKHA5 TAL1 CHMP4C CCSAP ZBTB33 FN1 APC ZDBF2 ADNP CREBBP RBM20 NCOR2 KMT2D LATS2 LMO7 ANKRD17 SMARCC2 CROCC CABIN1 ZMYM3 SMAD2 | 9.84e-07 | 1108 | 261 | 35 | int:HDAC1 |
| Interaction | YWHAZ interactions | TANC2 DLG5 DENND4A HIVEP1 TEX2 EXPH5 RB1CC1 ERBIN PTPN13 PTPRA MAST4 SIK2 KMT2A PLEKHA5 AFDN CEP126 CENATAC NOS1 WNK2 TLK2 CHMP4C ZBTB33 FN1 ARHGEF5 APC PTPN21 MAP7 EPN2 CCDC88C PTPDC1 LATS2 LMO7 SH3PXD2A MDC1 ANKRD17 UNK R3HDM1 PCDH7 GAB1 | 1.15e-06 | 1319 | 261 | 39 | int:YWHAZ |
| Interaction | SMAP2 interactions | HIP1 RNF214 UBAP2L SEC24B NOTCH2 RC3H2 CEP85 FN1 BMP2K EPN2 HGS UNK R3HDM1 | 1.17e-06 | 189 | 261 | 13 | int:SMAP2 |
| Interaction | HNF1B interactions | HIVEP1 MAML1 ZEB2 MEF2D HIRA KMT2C WIZ GSE1 CREBBP NCOR2 KMT2D ARID2 CABIN1 | 1.24e-06 | 190 | 261 | 13 | int:HNF1B |
| Interaction | MYB interactions | SP100 HIVEP1 HLF PHF8 ZEB2 WIZ KMT2A ZBTB33 CREBBP KMT2D ZNF292 | 1.31e-06 | 133 | 261 | 11 | int:MYB |
| Interaction | PAX6 interactions | NCOA6 HIVEP1 QRICH1 ZEB2 KMT2C SALL1 WIZ GSE1 TLK2 MORC2 CREBBP NCOR2 KMT2D ARID2 HGS SMARCC2 CABIN1 ZMYM3 | 1.50e-06 | 366 | 261 | 18 | int:PAX6 |
| Interaction | PARD3 interactions | DLG5 ERBIN PTPN13 AMOT PLEKHA5 AFDN NOTCH2 APC CCDC88C LATS2 LMO7 FARP1 GAB1 SMAD2 EPHA4 EPHA7 | 1.88e-06 | 298 | 261 | 16 | int:PARD3 |
| Interaction | MAML2 interactions | 1.91e-06 | 17 | 261 | 5 | int:MAML2 | |
| Interaction | RCOR1 interactions | SP100 HIVEP1 ACACB RB1CC1 ZEB2 NCAPG PTPN13 SALL1 GSE1 AMOT PLEKHA5 TAL1 ZBTB33 APC ZDBF2 RBM20 NCOR2 KMT2D ANKRD17 SMARCC2 ZMYM3 | 2.07e-06 | 494 | 261 | 21 | int:RCOR1 |
| Interaction | YWHAE interactions | TANC2 DLG5 DENND4A HIVEP1 EXPH5 MCM10 RB1CC1 ERBIN PTPN13 MAST4 SIK2 KMT2A PLEKHA5 AFDN WNK2 CHMP4C RC3H2 ZBTB33 FN1 RNF31 ARHGEF5 APC TNS2 FASTKD2 PTPN21 MAP7 CCDC88C NCOR2 PTPDC1 LMO7 SH3PXD2A ANKRD17 SMARCC2 UNK R3HDM1 PCDH7 GAB1 | 2.44e-06 | 1256 | 261 | 37 | int:YWHAE |
| Interaction | KCNA3 interactions | DLG5 AUP1 LSG1 EXPH5 SEPTIN9 ERBIN RYR1 PRDM2 KMT2C PTPN13 UBAP2L SEC24B KMT2A PLEKHA5 AFDN DNAH5 ZBTB33 APC CC2D1B MORC2 PAPOLG CCDC88C HGS TLR3 EIF4G1 ANKRD17 EIF4G3 PCDH7 GAB1 | 3.30e-06 | 871 | 261 | 29 | int:KCNA3 |
| Interaction | TEAD1 interactions | HIVEP1 ZEB2 MEF2D KMT2C SALL1 WIZ GSE1 MORC2 CREBBP NCOR2 KMT2D ARID2 | 3.32e-06 | 176 | 261 | 12 | int:TEAD1 |
| Interaction | APC interactions | EXPH5 RB1CC1 ERBIN OTUD7B PTPN13 WIZ AMOT AFDN CEP85 RNF31 SYNE1 APC CREBBP LATS2 HEY1 HGS ANKRD17 MBD5 | 3.53e-06 | 389 | 261 | 18 | int:APC |
| Interaction | KDM1A interactions | HDAC11 DLG5 HIVEP1 ACACB PHF8 RB1CC1 ZEB2 MEF2D PRDM2 OTUD7B NCAPG PTPN13 WIZ GSE1 AMOT PLEKHA5 TAL1 ZBTB33 MCPH1 APC ZDBF2 ADNP RBM20 PHC2 NCOR2 KMT2D ANKRD17 SMARCC2 UNK ZMYM3 | 5.24e-06 | 941 | 261 | 30 | int:KDM1A |
| Interaction | NOTCH4 interactions | 6.02e-06 | 21 | 261 | 5 | int:NOTCH4 | |
| Interaction | CRX interactions | MAML1 QRICH1 ZEB2 HIRA KMT2C SALL1 WIZ TNS2 CREBBP NCOR2 KMT2D ARID2 HGS ZMYM3 | 6.17e-06 | 254 | 261 | 14 | int:CRX |
| Interaction | ZYX interactions | TANC2 DLG5 QRICH1 ERBIN UBE2N AMOT PLEKHA5 NOTCH2 FN1 BMP2K APC ARHGAP9 LATS2 LMO7 HGS PPP6R2 | 6.66e-06 | 329 | 261 | 16 | int:ZYX |
| Interaction | UBN1 interactions | 6.92e-06 | 77 | 261 | 8 | int:UBN1 | |
| Interaction | CTNNB1 interactions | TANC2 DLG5 RB1CC1 ERBIN OTUD7B MAGI2 TSC22D1 ZC3H11A PTPN13 PTPRA SALL1 UBE2N AMOT SEC24B KMT2A PLEKHA5 AFDN ZBTB33 NT5E APC ADNP CREBBP CCDC88C KMT2D LATS2 LMO7 UNK CROCC SMAD2 EPHA7 EPHA8 | 7.58e-06 | 1009 | 261 | 31 | int:CTNNB1 |
| Interaction | KCNE3 interactions | ABCA2 MCM10 PHF8 ERBIN TMEM200A PTPRA USP32 PLEKHA5 NOTCH3 PNN TOM1L1 CC2D1B MAP7 HGS EPHA7 | 7.95e-06 | 296 | 261 | 15 | int:KCNE3 |
| Interaction | GJD3 interactions | DLG5 HIP1 AUP1 TEX2 LSG1 COG3 ERBIN PTPN13 SEC24B TOX3 USP32 PLEKHA5 NOTCH2 SYNE1 EPN2 HGS PCDH7 GAB1 EPHA7 | 8.01e-06 | 454 | 261 | 19 | int:GJD3 |
| Interaction | NFIX interactions | HIVEP1 QRICH1 ZEB2 KMT2C SALL1 WIZ GSE1 KMT2A MORC2 NCOR2 KMT2D ARID2 SMARCC2 | 8.81e-06 | 227 | 261 | 13 | int:NFIX |
| Interaction | MYOD1 interactions | HIVEP1 ZEB2 KMT2C WIZ GSE1 CREBBP NCOR2 KMT2D HEY1 SMARCC2 CABIN1 SMAD2 | 9.02e-06 | 194 | 261 | 12 | int:MYOD1 |
| Interaction | KLF5 interactions | NCOA6 HIVEP1 MAML1 MEF2D KMT2C GSE1 CREBBP RBM20 NCOR2 KMT2D ARID2 SMAD2 | 9.51e-06 | 195 | 261 | 12 | int:KLF5 |
| Interaction | SFN interactions | TANC2 NCOA6 DENND4A TEX2 EXPH5 ERBIN PTPN13 MAST4 AMOT SIK2 KMT2A PLEKHA5 CHMP4C ZBTB33 ARHGEF5 APC LMTK2 CCDC88C LMO7 SH3PXD2A EIF4G1 ANKRD17 PCDH7 GAB1 | 1.25e-05 | 692 | 261 | 24 | int:SFN |
| Interaction | EN1 interactions | 1.33e-05 | 110 | 261 | 9 | int:EN1 | |
| Interaction | PAX8 interactions | 1.43e-05 | 111 | 261 | 9 | int:PAX8 | |
| Interaction | FOS interactions | NCOA6 HIVEP1 ACACB RPS6KA2 NR6A1 HIRA KMT2C WIZ CREBBP NCOR2 KMT2D LMO7 ARID2 ANKRD17 SMARCC2 | 1.48e-05 | 312 | 261 | 15 | int:FOS |
| Interaction | GSC interactions | 1.72e-05 | 87 | 261 | 8 | int:GSC | |
| Interaction | TLX1 interactions | HIVEP1 MAML1 ZEB2 MEF2D KMT2C SALL1 WIZ GSE1 CREBBP NCOR2 KMT2D | 1.84e-05 | 175 | 261 | 11 | int:TLX1 |
| Interaction | TNRC6A interactions | NCOA6 DLG5 RB1CC1 KMT2C UBAP2L AMOT SEC24B AFDN RC3H2 CEP85 RNF31 MDC1 ANKRD17 UNK | 1.86e-05 | 280 | 261 | 14 | int:TNRC6A |
| Interaction | LATS1 interactions | DLG5 E2F7 PTPN13 AMOT SEC24B PLEKHA5 NOTCH2 CEP85 NT5E U2SURP APC CREBBP CCDC88C COL18A1 PALS1 RIF1 LATS2 R3HDM1 | 1.89e-05 | 440 | 261 | 18 | int:LATS1 |
| Interaction | GIGYF1 interactions | TANC2 DENND4A RNF214 PTPN13 UBAP2L PLEKHA5 AFDN CEP85 TBC1D25 LATS2 SH3PXD2A | 2.04e-05 | 177 | 261 | 11 | int:GIGYF1 |
| Interaction | EPHA2 interactions | DLG5 ACACB RPS6KA2 ERBIN PTPN13 SEC24B PLEKHA5 AFDN DMD NOTCH2 ARHGEF5 TRIOBP RALGAPA2 EPN2 PALS1 LATS2 TENM3 HGS PCDH7 GAB1 SMAD2 EPHA4 EPHA7 EPHA8 | 2.33e-05 | 719 | 261 | 24 | int:EPHA2 |
| Interaction | LYN interactions | DLG5 SEPTIN9 PHF8 ERBIN PTPN13 TOX3 KMT2A PLEKHA5 AFDN DMD NOTCH2 NPHS1 ARHGEF5 TOM1L1 APC LMTK2 CREBBP CCDC88C FARP1 IGSF9B PCDH7 GAB1 EPHA4 EPHA7 | 2.38e-05 | 720 | 261 | 24 | int:LYN |
| Interaction | PNMA2 interactions | SP100 HIC2 MCM10 CTTNBP2NL WIZ PLEKHA5 MAP7 ADNP PTPDC1 LATS2 KIF18B NEURL4 SLX4 | 2.56e-05 | 251 | 261 | 13 | int:PNMA2 |
| Interaction | KLF8 interactions | HIVEP1 HIC2 PHF8 ZEB2 MEF2D PRDM2 WIZ MAP7 ADNP CREBBP NCOR2 KMT2D ARID2 EIF4G1 ZMYM3 | 2.76e-05 | 329 | 261 | 15 | int:KLF8 |
| Interaction | GCM1 interactions | 2.79e-05 | 68 | 261 | 7 | int:GCM1 | |
| Interaction | RBPJ interactions | SP100 MAML1 PHF8 MEF2D KMT2A NOTCH2 NOTCH3 ADNP CREBBP NCOR2 HEY1 SMARCC2 MAML2 | 2.90e-05 | 254 | 261 | 13 | int:RBPJ |
| Interaction | PAX7 interactions | 3.47e-05 | 124 | 261 | 9 | int:PAX7 | |
| Interaction | YAP1 interactions | NCOA6 RBPJL PHF8 ERBIN OTUD7B KMT2C ZC3H11A PTPN13 UBAP2L AMOT KMT2A AFDN RPRD2 ZBTB33 PNN TRIOBP PTPN21 ADNP CREBBP COL18A1 PALS1 KMT2D LATS2 ARID2 MDC1 TRAPPC10 SMARCC2 UNK IGSF9B GAB1 SMAD2 | 3.69e-05 | 1095 | 261 | 31 | int:YAP1 |
| Interaction | NUP35 interactions | NCOA6 AUP1 MAML1 QRICH1 MEF2D KMT2C GSE1 AFDN CEP85 SYNE1 CREBBP RBM20 TGFA HIVEP3 NCOR2 KMT2D ANKRD17 | 4.15e-05 | 424 | 261 | 17 | int:NUP35 |
| Interaction | MAML1 interactions | 4.43e-05 | 73 | 261 | 7 | int:MAML1 | |
| Interaction | PHF21A interactions | HIVEP1 ACACB RB1CC1 ZEB2 PTPN13 SALL1 GSE1 AMOT PLEKHA5 ZBTB33 APC ZDBF2 RBM20 KMT2D ZMYM3 | 4.44e-05 | 343 | 261 | 15 | int:PHF21A |
| Interaction | H3-3A interactions | HIVEP1 MCM10 PHF8 ZEB2 PRDM2 HIRA KMT2C WIZ KMT2A UNG ARHGEF5 MORC2 ADNP CREBBP PAPOLG RIF1 KMT2D ARID2 MDC1 SMARCC2 KIF18B CABIN1 ZMYM3 ZNF292 | 4.46e-05 | 749 | 261 | 24 | int:H3-3A |
| Interaction | KLF3 interactions | HIVEP1 ZEB2 MEF2D PRDM2 HIRA WIZ GSE1 KMT2A NCOR2 KMT2D ARID2 ZMYM3 | 4.48e-05 | 228 | 261 | 12 | int:KLF3 |
| Interaction | MKRN2 interactions | RB1CC1 MAGI2 RNF214 ZC3H11A PTPRA UBAP2L NOTCH2 NOTCH3 RC3H2 CEP85 APC TENM3 R3HDM1 EPHA4 EPHA7 EPHA8 | 4.57e-05 | 385 | 261 | 16 | int:MKRN2 |
| Interaction | GARRE1 interactions | SP100 RB1CC1 UBAP2L AMOT SEC24B SIK2 NOTCH2 CEP85 ANKRD17 UNK | 6.65e-05 | 167 | 261 | 10 | int:GARRE1 |
| Interaction | PTPN13 interactions | TANC2 PTPN13 PTPRA AMOT AFDN APC LATS2 HEY1 SH3PXD2A EPHA4 EPHA7 | 6.85e-05 | 202 | 261 | 11 | int:PTPN13 |
| Interaction | RHBDF2 interactions | AUP1 LSG1 ERBIN TMEM200A UBE2N PLEKHA5 NOTCH2 PCDHB3 IGDCC4 HGS | 7.00e-05 | 168 | 261 | 10 | int:RHBDF2 |
| Interaction | CDAN1 interactions | 7.18e-05 | 34 | 261 | 5 | int:CDAN1 | |
| Interaction | CDIN1 interactions | 7.18e-05 | 34 | 261 | 5 | int:CDIN1 | |
| Interaction | MEN1 interactions | NCOA6 LSG1 PHF8 ERBIN MEF2D HIRA KMT2C ZC3H11A WIZ GSE1 KMT2A AFDN UNG PMS2 PNN U2SURP SYBU ADNP RIF1 KMT2D LMO7 FARP1 ARID2 MDC1 EIF4G1 ANKRD17 SMARCC2 ZMYM3 SMAD2 | 7.25e-05 | 1029 | 261 | 29 | int:MEN1 |
| Interaction | CEP85 interactions | 7.35e-05 | 169 | 261 | 10 | int:CEP85 | |
| Interaction | CAV1 interactions | DLG5 DENND4A SEPTIN9 RPS6KA2 COG3 ERBIN NEO1 PTPN13 UBE2N SEC24B PLEKHA5 AFDN NOTCH2 TOM1L1 APC LMTK2 TNS2 HGS PCDH7 GAB1 SMAD2 EPHA4 EPHA7 | 7.36e-05 | 724 | 261 | 23 | int:CAV1 |
| Interaction | TPRX2 interactions | 8.41e-05 | 56 | 261 | 6 | int:TPRX2 | |
| Interaction | PML interactions | HDAC11 SP100 SEPTIN9 NAB1 QRICH1 MCM10 CTTNBP2NL MEF2D HIRA PYHIN1 ZC3H11A NCAPG UBAP2L SEC24B KMT2A TLK2 PMS2 ZBTB33 CREBBP PAPOLG NCOR2 LMO7 MDC1 EIF4G1 SLX4 ZMYM3 SMAD2 | 8.41e-05 | 933 | 261 | 27 | int:PML |
| Interaction | KRT19 interactions | DLG5 RB1CC1 AMOT USP32 PLEKHA5 DMD CEP85 FN1 RNF31 PNN APC CEP164 HGS | 8.46e-05 | 282 | 261 | 13 | int:KRT19 |
| Interaction | H3C3 interactions | HIVEP1 PHF8 ZEB2 PRDM2 HIRA CDAN1 WIZ KMT2A UNG MORC2 ADNP RIF1 ARID2 MDC1 SMARCC2 KIF18B ZMYM3 ZNF292 | 8.68e-05 | 495 | 261 | 18 | int:H3C3 |
| Interaction | SUPT5H interactions | HIVEP1 MCM10 PHF8 ZEB2 PYHIN1 RNF214 GSE1 KMT2A RPRD2 FN1 PNN U2SURP TNS2 NCOR2 KMT2D SLX4 | 9.04e-05 | 408 | 261 | 16 | int:SUPT5H |
| Interaction | SIPA1L1 interactions | TANC2 DENND4A PTPN13 AMOT PLEKHA5 AFDN TBC1D25 RALGAPA2 LATS2 SH3PXD2A | 9.38e-05 | 174 | 261 | 10 | int:SIPA1L1 |
| Interaction | YY1 interactions | SP100 HIVEP1 GON4L WIZ KMT2A MORC2 ADNP CREBBP CEP164 ARHGEF15 RIF1 ARID2 MDC1 CABIN1 SLX4 ZMYM3 SMAD2 | 9.59e-05 | 454 | 261 | 17 | int:YY1 |
| Interaction | LINC00839 interactions | 1.01e-04 | 83 | 261 | 7 | int:LINC00839 | |
| Interaction | CABIN1 interactions | 1.01e-04 | 83 | 261 | 7 | int:CABIN1 | |
| Interaction | DTX2 interactions | ACACB ERBIN GSE1 RPRD2 NOTCH2 NOTCH3 CEP85 NCOR2 LATS2 MDC1 HGS EIF4G1 R3HDM1 CROCC | 1.10e-04 | 330 | 261 | 14 | int:DTX2 |
| Interaction | CREBBP interactions | NCOA6 SP100 HIVEP1 RPS6KA2 HLF MAML1 NR6A1 RB1CC1 KMT2A TAL1 APC CREBBP NCOR2 KMT2D MDC1 SMARCC2 XAF1 MAML2 SLX4 SMAD2 | 1.13e-04 | 599 | 261 | 20 | int:CREBBP |
| Interaction | H2BC21 interactions | PHF8 PRDM2 HIRA WIZ MSL3 KMT2A RPRD2 DNAH5 PNN CC2D1B ADNP CREBBP PHC2 RIF1 USF3 LATS2 ARID2 MDC1 SMARCC2 KIF18B ZMYM3 ZNF292 | 1.14e-04 | 696 | 261 | 22 | int:H2BC21 |
| Interaction | TLX3 interactions | NCOA6 DENND4A HIVEP1 RBPJL MAML1 KMT2C SALL1 WIZ GSE1 NCOR2 KMT2D ANKRD33 ARID2 | 1.16e-04 | 291 | 261 | 13 | int:TLX3 |
| Interaction | H3C1 interactions | HDAC11 PHF8 PRDM2 HIRA CDAN1 KMT2C WIZ MSL3 KMT2A UNG TLK2 SYNE1 U2SURP MORC2 ADNP CREBBP RIF1 KMT2D ARID2 MDC1 EIF4G1 SMARCC2 KIF18B MBD5 CABIN1 ZNF292 | 1.20e-04 | 901 | 261 | 26 | int:H3C1 |
| Interaction | EPHB2 interactions | SEPTIN9 PTPN13 SEC24B PLEKHA5 AFDN NOTCH2 ARHGEF15 HGS GAB1 EPHA4 EPHA7 | 1.24e-04 | 216 | 261 | 11 | int:EPHB2 |
| Interaction | RAB3IP interactions | 1.27e-04 | 115 | 261 | 8 | int:RAB3IP | |
| Interaction | UBN2 interactions | 1.57e-04 | 89 | 261 | 7 | int:UBN2 | |
| Interaction | CALM3 interactions | HIP1 DENND4A CTTNBP2NL AMOT RC3H2 PNN LMTK2 PALS1 LMO7 UNK PCDH7 EPHA4 EPHA7 EPHA8 | 1.64e-04 | 343 | 261 | 14 | int:CALM3 |
| Interaction | ERG interactions | NCOA6 HIVEP1 MAML1 MEF2D KMT2C GSE1 CREBBP NCOR2 KMT2D SMARCC2 SLX4 | 1.65e-04 | 223 | 261 | 11 | int:ERG |
| Interaction | GSK3B interactions | DLG5 DENND4A ACACB TEX2 LSG1 SEPTIN9 ERBIN CTTNBP2NL PTPN13 MAST4 SCML1 PLEKHA5 DMBT1 NOTCH2 NOTCH3 RC3H2 APC TRIOBP ZDBF2 MAP7 TLR3 EIF4G1 UNK SLX4 GAB1 | 1.67e-04 | 868 | 261 | 25 | int:GSK3B |
| Interaction | DIRAS3 interactions | DLG5 HIP1 PTPN13 PLEKHA5 NOTCH2 APC EPN2 FARP1 HGS PCDH7 GAB1 EPHA7 | 1.68e-04 | 262 | 261 | 12 | int:DIRAS3 |
| Interaction | RIF1 interactions | HDAC11 PHF8 HIRA CDAN1 AMOT CEP126 TLK2 RIF1 MDC1 ANKRD24 CABIN1 | 1.78e-04 | 225 | 261 | 11 | int:RIF1 |
| Interaction | XAGE1A interactions | 1.79e-04 | 41 | 261 | 5 | int:XAGE1A | |
| Interaction | CRKL interactions | SP100 NOTCH2 ARHGEF5 TNS2 ARHGAP9 PHC2 PTPDC1 SLX4 GAB1 EPHA4 EPHA8 | 1.92e-04 | 227 | 261 | 11 | int:CRKL |
| Interaction | TLK2 interactions | 2.07e-04 | 93 | 261 | 7 | int:TLK2 | |
| Cytoband | 17q25 | 7.84e-05 | 39 | 267 | 4 | 17q25 | |
| GeneFamily | PDZ domain containing | DLG5 PDZD7 ERBIN MAGI2 PTPN13 MAST4 AFDN NOS1 CARD14 PALS1 LMO7 | 1.80e-07 | 152 | 168 | 11 | 1220 |
| GeneFamily | Fibronectin type III domain containing | NEO1 NPHS1 ROBO4 FN1 COL20A1 IGDCC4 IGSF9B EPHA4 EPHA7 EPHA8 | 2.52e-06 | 160 | 168 | 10 | 555 |
| GeneFamily | Zinc fingers CCCH-type | 1.69e-05 | 35 | 168 | 5 | 73 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 9.17e-05 | 26 | 168 | 4 | 904 | |
| GeneFamily | Sterile alpha motif domain containing | 1.70e-04 | 88 | 168 | 6 | 760 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.66e-04 | 14 | 168 | 3 | 1095 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.68e-04 | 34 | 168 | 4 | 487 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.30e-04 | 15 | 168 | 3 | 529 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 6.84e-04 | 19 | 168 | 3 | 50 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.48e-03 | 53 | 168 | 4 | 532 | |
| GeneFamily | PHD finger proteins | 1.52e-03 | 90 | 168 | 5 | 88 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.56e-03 | 25 | 168 | 3 | 775 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP100 HIVEP1 SEPTIN9 RPS6KA2 PHF8 RB1CC1 ZEB2 HIRA PTPN13 PTPRA GSE1 SEC24B DMD TLK2 BMP2K U2SURP APC ADNP CREBBP ADGRG6 NCOR2 RIF1 ANKRD17 R3HDM1 EIF4G3 EPHA4 ZNF292 | 1.84e-07 | 856 | 264 | 27 | M4500 |
| Coexpression | GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN | TEX2 SEPTIN9 RALGDS SYT3 GDF15 TNS2 ZXDB LMO7 TRAPPC10 GAB1 EPHA4 | 6.38e-06 | 200 | 264 | 11 | M8217 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | HIVEP1 PIWIL1 SCML1 KMT2A PCDHB3 RIF1 USF3 CD27 IGSF9B MAML2 | 2.35e-05 | 189 | 264 | 10 | M3112 |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP | 3.07e-05 | 195 | 264 | 10 | M4195 | |
| Coexpression | MATZUK_SPERMATID_DIFFERENTIATION | 3.34e-05 | 37 | 264 | 5 | MM1235 | |
| Coexpression | MATZUK_SPERMATID_DIFFERENTIATION | 3.34e-05 | 37 | 264 | 5 | M1832 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_LUNG_DN | B4GALNT1 MAPK8IP3 OTUD7B ZC3H11A PTPN13 KMT2A DMBT1 SYNE1 APC CCDC88C | 3.65e-05 | 199 | 264 | 10 | M4350 |
| Coexpression | GSE7852_THYMUS_VS_FAT_TCONV_DN | HIP1 DENND4A RYR1 TSC22D1 SIK2 NOTCH2 BMP2K KCTD17 LATS2 FARP1 | 3.81e-05 | 200 | 264 | 10 | M5750 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | HDAC11 HLF HOXA3 MAGI2 TSC22D1 KMT2A PLEKHA5 DMD TAL1 RC3H2 FN1 ARHGEF5 ZDBF2 PTPN21 MAP7 COL18A1 LATS2 TENM3 CD27 EPHA7 | 4.77e-05 | 721 | 264 | 20 | M1999 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 ABCA2 TEX2 HLF ERBIN ZEB2 MAPK8IP3 HIRA TSC22D1 NEO1 CDH20 ZNF579 TLK2 CCSAP RALGDS PNN COL20A1 SYNE1 PTPDC1 LATS2 HEY1 IGSF9B CABIN1 PCDH7 GAB1 EPHA7 | 5.51e-05 | 1102 | 264 | 26 | M2369 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | DENND4A HIVEP1 MIER3 HIC2 RB1CC1 PRDM2 UBAP2L SCML1 MCPH1 TBC1D25 ZDBF2 FASTKD2 RALGAPA2 RIF1 LATS2 TRAPPC10 UNK EIF4G3 ZNF292 | 6.71e-05 | 680 | 264 | 19 | M41089 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 ABCA2 TEX2 HLF ERBIN ZEB2 MAPK8IP3 HIRA TSC22D1 NEO1 CDH20 ZNF579 TLK2 CCSAP RALGDS PNN COL20A1 SYNE1 PTPDC1 LATS2 HEY1 IGSF9B CABIN1 PCDH7 GAB1 EPHA7 | 7.61e-05 | 1124 | 264 | 26 | MM1070 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | SP100 ABCA2 ACACB PTPN13 SALL1 GSE1 TOX3 CEP126 ZNF579 DMD WNK2 MAPK8IP1 ROBO4 PNN PRR36 ARHGEF5 U2SURP ZDBF2 RALGAPA2 PAPOLG HIVEP3 CCDC88C PTPDC1 CD27 ZFHX2 XAF1 EPHA4 ZNF292 EPHA7 | 1.13e-05 | 986 | 259 | 29 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | TANC2 HDAC11 DLG5 DENND4A CTTNBP2NL PYHIN1 NCAPG ADAMTS17 ROBO4 PNN SYT3 CD248 SYNE1 UVSSA FASTKD2 CREBBP IGDCC4 ADGRG6 PTPDC1 CD27 SMARCC2 XAF1 ANKRD24 ZMYM3 EPHA7 | 3.46e-05 | 834 | 259 | 25 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TANC2 DENND4A MIER3 COG3 ZC3H6 CTTNBP2NL ZEB2 MAGI2 NEO1 SALL1 UBE2N TOX3 ADAMTS15 RPRD2 TBX4 NT5E U2SURP PCDHB3 RBM20 ZXDB RIF1 LMO7 EPHA4 ZNF292 EPHA7 | 3.59e-05 | 836 | 259 | 25 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | NAB1 MAML1 XYLT1 PTPN13 SALL1 WIZ SCML1 TOX3 KMT2A DMD NOTCH2 NOTCH3 | 3.20e-09 | 199 | 267 | 12 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | NR6A1 PTPN13 MAST4 TOX3 PLEKHA5 AFDN TOM1L1 MAP7 LMO7 FARP1 SLC4A4 | 2.62e-08 | 193 | 267 | 11 | 3866667dd221612589ae50f5c52f73a183a49ce6 |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | ZEB2 HOXA3 MAGI2 NOTCH2 TBX4 FN1 CD248 TENM3 MAML2 SLC4A4 PCDH7 | 3.07e-08 | 196 | 267 | 11 | dca52c57ba35d9395cdbca8b881f12ece721b10f |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PTPN13 MAST4 TOX3 DNAH5 WNK2 NOTCH3 NT5E GDF15 LMO7 FARP1 EPHA7 | 3.41e-08 | 198 | 267 | 11 | 1408e02e053ad3406229bfe8189da03be6366e81 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PTPN13 MAST4 TOX3 DNAH5 WNK2 NOTCH3 NT5E GDF15 LMO7 FARP1 EPHA7 | 3.41e-08 | 198 | 267 | 11 | af399569c718f5fd971d73a7926768c9311002a3 |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | PTPN13 MAST4 TOX3 DNAH5 WNK2 GDF15 SYBU MAP7 LMO7 FARP1 SLC4A4 | 3.41e-08 | 198 | 267 | 11 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | TANC2 DLG5 HIC2 GSE1 KMT2A WNK2 RALGDS PCDHB3 ADNP EIF4G3 PCDH7 | 3.78e-08 | 200 | 267 | 11 | c92e4fc0442404481fcac623d691dae6215b852d |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DENND4A RPS6KA2 MCM10 F8 ANKRD53 MAST4 SH3PXD2A ZFHX2 IGSF9B SYNGR4 | 1.05e-07 | 174 | 267 | 10 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | HIP1 XYLT1 CDH20 ADAMTS17 NOTCH2 COL20A1 NT5E EPN2 TGFA MAML2 | 1.60e-07 | 182 | 267 | 10 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | HIP1 XYLT1 CDH20 ADAMTS17 NOTCH2 COL20A1 NT5E EPN2 TGFA MAML2 | 1.60e-07 | 182 | 267 | 10 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 2.06e-07 | 187 | 267 | 10 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | HIP1 ACACB PTPN13 ADAMTS15 SYNE1 LMO7 FARP1 ANKRD17 MAML2 MBD5 | 2.27e-07 | 189 | 267 | 10 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 2.38e-07 | 190 | 267 | 10 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | TANC2 RPS6KA2 ZEB2 XYLT1 MAST4 TAL1 NOX4 ARHGEF15 HIVEP3 XAF1 | 2.63e-07 | 192 | 267 | 10 | e09f609fed033a25baacaf4a07bbbae1076da366 |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | SEPTIN9 ZEB2 TMEM200A SLC35F6 NOTCH2 NOTCH3 TBX4 CD248 ARHGAP9 ADGRG6 | 2.63e-07 | 192 | 267 | 10 | 063e119c4b58957643908f667e6cfd6f7517fd03 |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 2.76e-07 | 193 | 267 | 10 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RPS6KA2 SALL1 CLDN20 TAL1 FN1 PCDHB3 RALGAPA2 ADGRG6 COL18A1 MAML2 | 2.76e-07 | 193 | 267 | 10 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.03e-07 | 195 | 267 | 10 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.49e-07 | 198 | 267 | 10 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-07 | 200 | 267 | 10 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-07 | 158 | 267 | 9 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-07 | 158 | 267 | 9 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-07 | 158 | 267 | 9 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | COVID-19_Moderate-MAIT|COVID-19_Moderate / disease group, cell group and cell class | 5.22e-07 | 159 | 267 | 9 | 6d08d670c34eb6bb8ad5dad3293b3107c006236d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.50e-07 | 166 | 267 | 9 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.71e-07 | 169 | 267 | 9 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.15e-07 | 170 | 267 | 9 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-06 | 176 | 267 | 9 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | DLG5 B4GALNT1 RPS6KA2 TMEM200A IL23R RLN1 TGFA CCDC88C EPHA4 | 1.41e-06 | 179 | 267 | 9 | bc95c3e7edc5fc6fc913b09f087d221df64c6f48 |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 1.60e-06 | 135 | 267 | 8 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.85e-06 | 185 | 267 | 9 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.02e-06 | 187 | 267 | 9 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | EXPH5 TSC22D1 TOX3 ADAMTS17 NOS1 SPPL2A SH3PXD2A MAML2 INPP5J | 2.11e-06 | 188 | 267 | 9 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | EXPH5 TSC22D1 TOX3 ADAMTS17 NOS1 SPPL2A SH3PXD2A MAML2 INPP5J | 2.11e-06 | 188 | 267 | 9 | eec3d353e51358db4c7621265ee0fdd4298e5b0e |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.11e-06 | 188 | 267 | 9 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.20e-06 | 189 | 267 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 2.20e-06 | 189 | 267 | 9 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.30e-06 | 190 | 267 | 9 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | SEPTIN9 ZEB2 TMEM200A SLC35F6 NOTCH2 NOTCH3 ARHGAP9 ADGRG6 SLC4A4 | 2.30e-06 | 190 | 267 | 9 | 979b1476fd2692fde977ce56257315fcfc8a01d5 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.30e-06 | 190 | 267 | 9 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.30e-06 | 190 | 267 | 9 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.30e-06 | 190 | 267 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.40e-06 | 191 | 267 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-06 | 191 | 267 | 9 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.40e-06 | 191 | 267 | 9 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 192 | 267 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.61e-06 | 193 | 267 | 9 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.61e-06 | 193 | 267 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 193 | 267 | 9 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.73e-06 | 194 | 267 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-06 | 194 | 267 | 9 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.73e-06 | 194 | 267 | 9 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.85e-06 | 195 | 267 | 9 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 195 | 267 | 9 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.85e-06 | 195 | 267 | 9 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.97e-06 | 196 | 267 | 9 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.97e-06 | 196 | 267 | 9 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-06 | 196 | 267 | 9 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-06 | 196 | 267 | 9 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | 3.09e-06 | 197 | 267 | 9 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 | |
| ToppCell | PND14-Mesenchymal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-06 | 197 | 267 | 9 | 9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe | |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | 3.09e-06 | 197 | 267 | 9 | 15b87fd3906d7388c271d30d0c64b1bcc490801c | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.09e-06 | 197 | 267 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 5'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-06 | 198 | 267 | 9 | 90e85fe7a0ab376a41666dfff6c0e95b7f1c9475 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-06 | 198 | 267 | 9 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.36e-06 | 199 | 267 | 9 | 2b357cc08c425a58d45aa6c086101c8fff53e218 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.36e-06 | 199 | 267 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.50e-06 | 200 | 267 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19_Moderate-MAIT|World / disease group, cell group and cell class | 5.68e-06 | 160 | 267 | 8 | bf73c5fe87c1f243edec17d7a2c30fae5e2cfd6b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.81e-06 | 164 | 267 | 8 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 7.44e-06 | 166 | 267 | 8 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.77e-06 | 167 | 267 | 8 | d1a13d6ada572d8ddb2da95e6e122d2b705fad7f | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 7.77e-06 | 167 | 267 | 8 | 3ae46c6363da76c8e1f5579e6027bf88ed637a44 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.48e-06 | 169 | 267 | 8 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-06 | 169 | 267 | 8 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 8.86e-06 | 170 | 267 | 8 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-06 | 171 | 267 | 8 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-06 | 171 | 267 | 8 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-06 | 172 | 267 | 8 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-06 | 172 | 267 | 8 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 173 | 267 | 8 | f193c63cc536d891c9d23043765e320252bb6e65 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.24e-05 | 178 | 267 | 8 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|metastatic_Brain / Location, Cell class and cell subclass | 1.29e-05 | 179 | 267 | 8 | 56fe381ffbaba3a4f2f587a3e367b0d11fbd4a2a | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-05 | 179 | 267 | 8 | 3edcd1356e49b1f5514c585861999e079ca5e579 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-05 | 180 | 267 | 8 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 181 | 267 | 8 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 181 | 267 | 8 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 1.40e-05 | 181 | 267 | 8 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-Treg|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-05 | 183 | 267 | 8 | 5fb933acfe6bc555c90dba71e75d4be658763945 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.57e-05 | 184 | 267 | 8 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.57e-05 | 184 | 267 | 8 | 23c24ab5786af33d605bc445d06117b9da6c6331 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.57e-05 | 184 | 267 | 8 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.57e-05 | 184 | 267 | 8 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.57e-05 | 184 | 267 | 8 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-05 | 185 | 267 | 8 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-05 | 185 | 267 | 8 | e34473eea3a58c041183a4f52137366cd9489495 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.64e-05 | 185 | 267 | 8 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.64e-05 | 185 | 267 | 8 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.64e-05 | 185 | 267 | 8 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.70e-05 | 186 | 267 | 8 | db9b67066fc003c7995ec205d15176bf40c97add | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A | SP100 HIP1 ABCA2 DENND4A DMBT1 FN1 APC FASTKD2 RLN1 TGFA SLC5A5 NCOR2 R3HDM1 SLC4A4 CABIN1 | 1.06e-08 | 198 | 262 | 15 | 7391_UP |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | HDAC11 SP100 MAGI2 MAST4 WIZ ZBTB33 BMP2K PRR36 APC PTPN21 EPN2 RLN1 SLC4A4 PPP6R2 | 5.69e-08 | 193 | 262 | 14 | 3973_DN |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | HDAC11 ABCA2 SEPTIN9 GON4L KMT2A NOS1 ZBTB33 TRIOBP PODXL2 TENM3 ZFHX2 SLC4A4 PPP6R2 | 4.79e-07 | 196 | 262 | 13 | 2755_DN |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A | ABCA2 B4GALNT1 HIC2 PRDM2 MAPK8IP3 MAST4 WIZ SIK2 APC PODXL2 CEP164 PAPOLG CABIN1 | 5.08e-07 | 197 | 262 | 13 | 7052_UP |
| Drug | Rimexolone [49697-38-3]; Down 200; 10.8uM; PC3; HT_HG-U133A | DENND4A EXPH5 NAB1 HIRA PTPRA UBAP2L SLC35F6 TIMM17A BMP2K GDF15 ASTE1 EPN2 | 2.91e-06 | 195 | 262 | 12 | 5092_DN |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | ACACB NR6A1 BDKRB1 AFDN DMD MCPH1 CD248 KLK12 CEP164 KCTD17 RLN1 TGFA | 2.91e-06 | 195 | 262 | 12 | 5574_UP |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | HIP1 B4GALNT1 HIVEP1 PRDM2 MAPK8IP3 MSL3 NOTCH3 CEP85 APC HIVEP3 NCOR2 SLC4A4 | 3.07e-06 | 196 | 262 | 12 | 7269_UP |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | DLG5 SP100 ABCA2 RPS6KA2 HIRA PTPRA UBAP2L KMT2A SYBU TGFA HIVEP3 GAB1 | 3.07e-06 | 196 | 262 | 12 | 1666_UP |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | RPS6KA2 MEF2D AFDN FN1 BMP2K PRR36 KLK12 SYBU PTPN21 SLC5A5 CABIN1 INPP5J | 3.23e-06 | 197 | 262 | 12 | 6241_UP |
| Drug | clozapine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | SP100 HIP1 ABCA2 PRDM2 PTPRA ZBTB33 BMP2K NT5E PODXL2 PTPN21 RANGRF CABIN1 | 3.59e-06 | 199 | 262 | 12 | 1009_UP |
| Drug | Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A | HIP1 ABCA2 RYR1 MAGI2 MAST4 WIZ UBAP2L TIMM17A KMT2A AFDN NOTCH2 KCTD17 | 3.78e-06 | 200 | 262 | 12 | 6005_UP |
| Drug | Tetrandrine [518-34-3]; Up 200; 6.4uM; MCF7; HT_HG-U133A | SP100 EXPH5 RB1CC1 MAPK8IP3 TSC22D1 SCML1 SIK2 TIMM17A GDF15 APC ZNF292 | 6.52e-06 | 176 | 262 | 11 | 7178_UP |
| Drug | Piretanide [55837-27-9]; Up 200; 11uM; HL60; HT_HG-U133A | DLG5 ABCA2 ACACB WIZ ACAN DMD CD248 PODXL2 CEP164 PAPOLG PALS1 | 1.49e-05 | 192 | 262 | 11 | 6144_UP |
| Drug | Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; MCF7; HT_HG-U133A | SP100 ACACB NR6A1 KMT2A TAL1 CD248 KCTD17 NCOR2 XAF1 INPP5J GAB1 | 1.56e-05 | 193 | 262 | 11 | 4146_UP |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A | TANC2 SP100 B4GALNT1 ACACB HIC2 MAPK8IP3 TIMM17A DMBT1 PODXL2 HEY1 ZFHX2 | 1.56e-05 | 193 | 262 | 11 | 2078_UP |
| Drug | Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; PC3; HT_HG-U133A | HDAC11 ABCA2 NAB1 MAPK8IP3 AFDN NOTCH2 FASTKD2 PTPN21 EPN2 NCOR2 FARP1 | 1.64e-05 | 194 | 262 | 11 | 6616_DN |
| Drug | Lisinopril [83915-83-7]; Up 200; 9uM; MCF7; HT_HG-U133A | RPS6KA2 PHF8 F8 AFDN NOS1 APC PTPN21 CREBBP PAPOLG CCDC88C PPP6R2 | 1.72e-05 | 195 | 262 | 11 | 7403_UP |
| Drug | Homosalate [118-56-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | SEPTIN9 PIWIL1 NR6A1 RYR1 PYHIN1 NPHS1 ZBTB33 APC KCTD17 HEY1 LMO7 | 1.72e-05 | 195 | 262 | 11 | 4355_UP |
| Drug | Calycanthine [595-05-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | HIP1 ABCA2 WIZ NOTCH2 APC TRIOBP FASTKD2 CCDC88C LMO7 CABIN1 EPHA4 | 1.72e-05 | 195 | 262 | 11 | 5744_DN |
| Drug | PF-00875133-00 [351322-64-0]; Down 200; 10uM; PC3; HT_HG-U133A | HDAC11 SP100 SEPTIN9 MEF2D HOXA3 YIPF2 AFDN U2SURP APC ZFHX2 SLC4A4 | 1.80e-05 | 196 | 262 | 11 | 5928_DN |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | MAGI2 MAST4 WIZ UBAP2L BMP2K PRR36 LMTK2 SLC5A5 ZFHX2 CABIN1 PPP6R2 | 1.80e-05 | 196 | 262 | 11 | 5604_DN |
| Drug | Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; MCF7; HT_HG-U133A | ACACB HLF SH3BP1 NR6A1 PRDM2 AMOT KMT2A MCPH1 NCOR2 SLC4A4 GAB1 | 1.80e-05 | 196 | 262 | 11 | 3903_UP |
| Drug | SB 202190; Up 200; 1uM; MCF7; HT_HG-U133A | ABCA2 B4GALNT1 GON4L MEF2D MAPK8IP3 HOXA3 APC PODXL2 SYBU PTPN21 PPP6R2 | 1.80e-05 | 196 | 262 | 11 | 7054_UP |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A | ABCA2 EXPH5 RPS6KA2 HIC2 PHF8 MAST4 TIMM17A NOS1 SYBU EPN2 RIF1 | 1.89e-05 | 197 | 262 | 11 | 6265_UP |
| Drug | WY-14643; Up 200; 100uM; PC3; HG-U133A | ACACB NR6A1 PRDM2 YIPF2 PTPRA WIZ ACAN RALGDS PMS2 FARP1 SLC4A4 | 1.89e-05 | 197 | 262 | 11 | 464_UP |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; PC3; HT_HG-U133A | HIP1 ABCA2 RPS6KA2 MAPK8IP3 SLC35F6 TIMM17A NOTCH2 FN1 CEP164 KCTD17 CCDC88C | 1.89e-05 | 197 | 262 | 11 | 5752_DN |
| Drug | Podophyllotoxin [518-28-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | ACACB MAST4 MSL3 KMT2A RALGDS FN1 CEP164 RLN1 SLC5A5 CABIN1 INPP5J | 1.89e-05 | 197 | 262 | 11 | 6103_DN |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; HL60; HT_HG-U133A | HIP1 RPS6KA2 NAB1 GON4L F8 PRDM2 NOTCH2 BMP2K SLC4A4 PPP6R2 EPHA4 | 1.89e-05 | 197 | 262 | 11 | 2975_DN |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; PC3; HT_HG-U133A | TANC2 NAB1 MAML1 BDKRB1 YIPF2 SYNE1 APC PTPN21 KCTD17 LMO7 SLC4A4 | 1.98e-05 | 198 | 262 | 11 | 3711_DN |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A | DLG5 SEPTIN9 HIC2 MEF2D RALGDS SYNE1 PODXL2 PTPN21 MORC2 PAPOLG INPP5J | 1.98e-05 | 198 | 262 | 11 | 2124_UP |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | SP100 B4GALNT1 ACACB MAPK8IP3 HIRA NOTCH2 RALGDS GDF15 SYNE1 ZFHX2 CABIN1 | 1.98e-05 | 198 | 262 | 11 | 2128_UP |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | SP100 RPS6KA2 HIRA YIPF2 RALGDS PODXL2 EPN2 CCDC88C SMARCC2 PPP6R2 ZNF292 | 2.07e-05 | 199 | 262 | 11 | 6950_DN |
| Drug | vgBE | 2.94e-05 | 6 | 262 | 3 | CID000193461 | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; PC3; HT_HG-U133A | 8.11e-05 | 192 | 262 | 10 | 6734_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A | RPS6KA2 NR6A1 MAPK8IP3 CARD14 PRR36 GDF15 KCTD17 ZFHX2 CABIN1 GAB1 | 8.11e-05 | 192 | 262 | 10 | 2807_UP |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | HDAC11 B4GALNT1 HIRA PTPRA NOTCH2 NOTCH3 SYNE1 TRIOBP TGFA XAF1 | 8.11e-05 | 192 | 262 | 10 | 2123_UP |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | HDAC11 SP100 DENND4A HIRA YIPF2 BMP2K PODXL2 FASTKD2 RIF1 ZFHX2 | 8.47e-05 | 193 | 262 | 10 | 4406_DN |
| Drug | Theobromine [83-67-0]; Down 200; 22.2uM; PC3; HT_HG-U133A | 8.47e-05 | 193 | 262 | 10 | 6613_DN | |
| Drug | Prednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | DENND4A GON4L MAST4 SLC35F6 TIMM17A KMT2A RC3H2 RNF31 GDF15 PAPOLG | 8.47e-05 | 193 | 262 | 10 | 5119_DN |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 8.47e-05 | 193 | 262 | 10 | 4410_DN | |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | SP100 SEPTIN9 RPS6KA2 PRDM2 PTPRA NOTCH3 CEP164 ZFHX2 SMARCC2 PPP6R2 | 8.84e-05 | 194 | 262 | 10 | 5362_UP |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 8.84e-05 | 194 | 262 | 10 | 4182_UP | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | DENND4A SEPTIN9 PDZD7 PRDM2 PTPRA GSE1 RNF31 U2SURP APC TRAPPC10 | 8.84e-05 | 194 | 262 | 10 | 2504_DN |
| Drug | Thiocolchicoside [602-41-5]; Down 200; 7uM; MCF7; HT_HG-U133A | MAPK8IP3 MAST4 MSL3 SIK2 NOTCH2 BMP2K U2SURP EPN2 TRAPPC10 ZNF292 | 9.22e-05 | 195 | 262 | 10 | 5520_DN |
| Drug | N6-methyladenosine [1867-73-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 9.22e-05 | 195 | 262 | 10 | 2626_UP | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 9.22e-05 | 195 | 262 | 10 | 7309_UP | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HT_HG-U133A | 9.22e-05 | 195 | 262 | 10 | 6761_UP | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | SEPTIN9 RPS6KA2 MAML1 HIC2 MAST4 FN1 TRIOBP HIVEP3 CROCC PPP6R2 | 9.62e-05 | 196 | 262 | 10 | 3353_DN |
| Drug | Kaempferol [520-18-3]; Up 200; 14uM; MCF7; HT_HG-U133A | 9.62e-05 | 196 | 262 | 10 | 3579_UP | |
| Drug | Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 9.62e-05 | 196 | 262 | 10 | 6273_UP | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | B4GALNT1 LSG1 RPS6KA2 F8 RNF31 BMP2K SYNE1 PTPN21 MAP7 CABIN1 | 9.62e-05 | 196 | 262 | 10 | 7377_DN |
| Drug | Colistin sulfate [1264-72-8]; Up 200; 3uM; PC3; HT_HG-U133A | 9.62e-05 | 196 | 262 | 10 | 4212_UP | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | HIP1 HIVEP1 RPS6KA2 MAPK8IP3 SLC35F6 NOTCH3 FN1 TNS2 ZFHX2 EPHA4 | 9.62e-05 | 196 | 262 | 10 | 5757_DN |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; PC3; HT_HG-U133A | ACACB SEPTIN9 MAST4 TIMM17A NOTCH3 RNF31 GDF15 SYNE1 TGFA EPHA4 | 9.62e-05 | 196 | 262 | 10 | 7155_UP |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; PC3; HT_HG-U133A | MAML1 HIC2 MEF2D PYHIN1 ACAN RNF31 KCTD17 PAPOLG ZFHX2 R3HDM1 | 9.62e-05 | 196 | 262 | 10 | 5052_UP |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A | HDAC11 RPS6KA2 PYHIN1 MAST4 WIZ KMT2A BMP2K PRR36 PTPN21 PCDH7 | 9.62e-05 | 196 | 262 | 10 | 3936_DN |
| Drug | Propafenone hydrochloride [34183-22-7]; Down 200; 10.6uM; MCF7; HT_HG-U133A | HIRA MAST4 MSL3 NOTCH3 RNF31 PRR36 CEP164 SLC5A5 FARP1 PCDH7 | 1.00e-04 | 197 | 262 | 10 | 5437_DN |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | B4GALNT1 MEF2D PYHIN1 ACAN RPRD2 PRR36 ARHGEF15 PAPOLG INPP5J SYNGR4 | 1.00e-04 | 197 | 262 | 10 | 4299_UP |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A | DENND4A EXPH5 MAST4 TIMM17A NOTCH2 OCEL1 BMP2K SYBU CROCC PCDH7 | 1.00e-04 | 197 | 262 | 10 | 7093_UP |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.00e-04 | 197 | 262 | 10 | 6611_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 262 | 10 | 3277_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A | SP100 ABCA2 MEF2D MAPK8IP3 TIMM17A SYNE1 PTPN21 TENM3 CROCC CABIN1 | 1.05e-04 | 198 | 262 | 10 | 7293_UP |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.05e-04 | 198 | 262 | 10 | 1529_UP | |
| Drug | Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A | B4GALNT1 EXPH5 PHF8 MSL3 NOTCH3 OCEL1 FN1 RNF31 SMARCC2 CABIN1 | 1.05e-04 | 198 | 262 | 10 | 6211_DN |
| Drug | Ebselen [60940-34-3]; Up 200; 14.6uM; PC3; HT_HG-U133A | NAB1 MAPK8IP3 PYHIN1 KMT2A APC ARHGEF15 KCTD17 CCDC88C RIF1 SYNGR4 | 1.05e-04 | 198 | 262 | 10 | 5778_UP |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; PC3; HT_HG-U133A | 1.05e-04 | 198 | 262 | 10 | 5104_UP | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.05e-04 | 198 | 262 | 10 | 4187_UP | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; MCF7; HT_HG-U133A | ACACB HIC2 BDKRB1 MAPK8IP3 CARD14 PTPN21 CREBBP CEP164 KCTD17 GAB1 | 1.05e-04 | 198 | 262 | 10 | 2294_UP |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | ABCA2 GON4L HIRA MAGI2 SEC24B NOTCH2 TNS2 PTPN21 CCDC88C HEY1 | 1.05e-04 | 198 | 262 | 10 | 6907_UP |
| Drug | pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A | SEPTIN9 MAPK8IP3 MSL3 APC PTPN21 PAPOLG HIVEP3 TENM3 ZFHX2 SLC4A4 | 1.05e-04 | 198 | 262 | 10 | 7506_DN |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; HL60; HT_HG-U133A | 1.09e-04 | 199 | 262 | 10 | 2179_UP | |
| Drug | Epitiostanol [2363-58-8]; Up 200; 13uM; PC3; HT_HG-U133A | 1.09e-04 | 199 | 262 | 10 | 4204_UP | |
| Drug | Methiazole; Up 200; 15uM; MCF7; HT_HG-U133A | 1.09e-04 | 199 | 262 | 10 | 3878_UP | |
| Drug | Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A | SP100 HIVEP1 HIC2 HIRA WIZ PSRC1 EPN2 COL18A1 SMARCC2 EIF4G3 | 1.09e-04 | 199 | 262 | 10 | 7203_DN |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.09e-04 | 199 | 262 | 10 | 4294_DN | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; PC3; HT_HG-U133A | TANC2 SP100 NAB1 PRDM2 KMT2A FN1 PTPN21 CCDC88C CROCC SYNGR4 | 1.09e-04 | 199 | 262 | 10 | 2109_UP |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | SP100 EXPH5 NR6A1 HOXA3 SIK2 AFDN LMTK2 EPN2 SH3PXD2A CABIN1 | 1.09e-04 | 199 | 262 | 10 | 3205_UP |
| Drug | Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.09e-04 | 199 | 262 | 10 | 2220_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.09e-04 | 199 | 262 | 10 | 3566_UP | |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; HL60; HT_HG-U133A | 1.09e-04 | 199 | 262 | 10 | 2572_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | ABCA2 MAST4 FN1 RNF31 BMP2K KCTD17 EPN2 SMARCC2 CROCC PPP6R2 | 1.09e-04 | 199 | 262 | 10 | 7439_UP |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; SKMEL5; HG-U133A | 1.09e-04 | 199 | 262 | 10 | 494_DN | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | HIP1 SEPTIN9 RPS6KA2 RYR1 PRDM2 DMBT1 TGFA COL18A1 LMO7 MSLN | 1.09e-04 | 199 | 262 | 10 | 5094_UP |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | RPS6KA2 NR6A1 MEF2D MAGEC1 FN1 CEP164 HIVEP3 COL18A1 SLC4A4 CABIN1 | 1.09e-04 | 199 | 262 | 10 | 2787_UP |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | SP100 HIP1 RPS6KA2 HLF NR6A1 HIRA CARD14 NPHS1 CREBBP SLC5A5 | 1.09e-04 | 199 | 262 | 10 | 3872_UP |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; HL60; HG-U133A | HIP1 MAPK8IP3 SCML1 KMT2A DMBT1 NOS1 RC3H2 CEP85 BMP2K HIVEP3 | 1.09e-04 | 199 | 262 | 10 | 1568_DN |
| Drug | Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; HL60; HT_HG-U133A | 1.09e-04 | 199 | 262 | 10 | 3032_UP | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | HDAC11 ABCA2 B4GALNT1 GON4L MAPK8IP3 ACAN FN1 BMP2K APC NCOR2 | 1.09e-04 | 199 | 262 | 10 | 6634_DN |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.09e-04 | 199 | 262 | 10 | 2744_DN | |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; PC3; HG-U133A | SEPTIN9 MAST4 UBAP2L SIK2 OCEL1 SLC5A5 FARP1 TRAPPC10 PPP6R2 ZMYM3 | 1.09e-04 | 199 | 262 | 10 | 1945_DN |
| Drug | Thyroxine (L) [51-48-9]; Down 200; 5.2uM; MCF7; HT_HG-U133A | HDAC11 RPS6KA2 F8 MAPK8IP3 YIPF2 WIZ RALGDS RNF31 PODXL2 PPP6R2 | 1.09e-04 | 199 | 262 | 10 | 3249_DN |
| Drug | Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; PC3; HT_HG-U133A | HDAC11 SP100 SEPTIN9 HLF MEF2D MAPK8IP3 ZBTB33 PODXL2 SLC5A5 HIVEP3 | 1.14e-04 | 200 | 262 | 10 | 6676_DN |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | HIC2 MAPK8IP3 HOXA3 NPHS1 RC3H2 FN1 CEP164 KCTD17 NCOR2 SH3PXD2A | 1.14e-04 | 200 | 262 | 10 | 2481_UP |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 1.14e-04 | 200 | 262 | 10 | 2272_UP | |
| Drug | Palmatine chloride [3486-67-7]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.14e-04 | 200 | 262 | 10 | 6612_DN | |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; HL60; HT_HG-U133A | TANC2 EXPH5 SEPTIN9 NAB1 SLC35F6 KMT2A NOTCH2 SYNE1 SLC4A4 GAB1 | 1.14e-04 | 200 | 262 | 10 | 3062_DN |
| Drug | F - OU | 1.20e-04 | 9 | 262 | 3 | CID011963539 | |
| Drug | phosphonitrilic chloride | 1.32e-04 | 2 | 262 | 2 | CID000076285 | |
| Drug | N-methylolmethacrylamide | 1.32e-04 | 2 | 262 | 2 | CID000070208 | |
| Drug | sulfenosine | 1.32e-04 | 2 | 262 | 2 | CID000129862 | |
| Disease | Colorectal Carcinoma | EFS ZEB2 KMT2C NCAPG GSE1 ADAMTS15 UNG DMD RALGDS PMS2 FN1 CD248 SYNE1 APC HIVEP3 LMO7 EIF4G1 XAF1 SMAD2 ZNF292 EPHA7 | 8.93e-07 | 702 | 254 | 21 | C0009402 |
| Disease | Prostatic Neoplasms | PYHIN1 KMT2C KMT2A RPRD2 RNF31 GDF15 ARHGEF5 TOM1L1 APC LMTK2 CREBBP TGFA SLC5A5 RLN2 KMT2D ARID2 ZMYM3 ZNF292 | 7.57e-06 | 616 | 254 | 18 | C0033578 |
| Disease | Malignant neoplasm of prostate | PYHIN1 KMT2C KMT2A RPRD2 RNF31 GDF15 ARHGEF5 TOM1L1 APC LMTK2 CREBBP TGFA SLC5A5 RLN2 KMT2D ARID2 ZMYM3 ZNF292 | 7.57e-06 | 616 | 254 | 18 | C0376358 |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 2.86e-05 | 21 | 254 | 4 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | Ependymoblastoma | 3.42e-05 | 8 | 254 | 3 | C0700367 | |
| Disease | Neuroectodermal Tumor, Primitive | 3.42e-05 | 8 | 254 | 3 | C0206663 | |
| Disease | Cerebral Primitive Neuroectodermal Tumor | 3.42e-05 | 8 | 254 | 3 | C0751675 | |
| Disease | Spongioblastoma | 3.42e-05 | 8 | 254 | 3 | C0334584 | |
| Disease | Medulloepithelioma | 3.42e-05 | 8 | 254 | 3 | C0334596 | |
| Disease | Malignant neoplasm of breast | NCOA6 AVPR2 RB1CC1 COG3 ZEB2 HOXA3 ZC3H11A CDH20 BEND7 TOX3 DMD NOTCH2 NOTCH3 FN1 SYT3 SYNE1 SLC5A5 RIF1 KMT2D LBX1 HEY1 FARP1 GAB1 | 6.16e-05 | 1074 | 254 | 23 | C0006142 |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 7.38e-05 | 2 | 254 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | cortical thickness | B4GALNT1 RPS6KA2 MAPK8IP3 NEO1 CDH20 MAST4 TOX3 SLC35F6 KMT2A WNK2 MCPH1 ADAMTS2 TRIOBP ACTRT2 SYBU RAB44 COL18A1 SH3PXD2A EIF4G3 PCDH7 ERCC6L2-AS1 EPHA4 EPHA7 | 1.05e-04 | 1113 | 254 | 23 | EFO_0004840 |
| Disease | Intellectual Disability | TANC2 GON4L QRICH1 MAPK8IP3 KMT2C MSL3 TLK2 RALGDS SYNE1 APC COL18A1 SMARCC2 ZNF292 | 1.48e-04 | 447 | 254 | 13 | C3714756 |
| Disease | Neurodevelopmental Disorders | 1.56e-04 | 93 | 254 | 6 | C1535926 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.82e-04 | 61 | 254 | 5 | C1961102 | |
| Disease | serum gamma-glutamyl transferase measurement | DLG5 SEPTIN9 GON4L ZC3H11B SALL1 GSE1 KMT2A TAL1 PSRC1 NOTCH2 LMTK2 TRIOBP ARHGEF15 NCOR2 SPPL2A RP1L1 CABIN1 PPP6R2 ZNF292 | 3.92e-04 | 914 | 254 | 19 | EFO_0004532 |
| Disease | Gastrointestinal Neoplasms | 4.38e-04 | 4 | 254 | 2 | C0017185 | |
| Disease | Malignant neoplasm of gastrointestinal tract | 4.38e-04 | 4 | 254 | 2 | C0685938 | |
| Disease | Glioblastoma | 6.10e-04 | 79 | 254 | 5 | C0017636 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 6.45e-04 | 20 | 254 | 3 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | chronic graft versus host disease | 7.26e-04 | 5 | 254 | 2 | MONDO_0020547 | |
| Disease | Duchenne muscular dystrophy (is_marker_for) | 7.26e-04 | 5 | 254 | 2 | DOID:11723 (is_marker_for) | |
| Disease | Turcot syndrome (disorder) | 7.26e-04 | 5 | 254 | 2 | C0265325 | |
| Disease | immunoglobulin superfamily DCC subclass member 4 measurement | 7.26e-04 | 5 | 254 | 2 | EFO_0801690 | |
| Disease | Giant Cell Glioblastoma | 8.07e-04 | 84 | 254 | 5 | C0334588 | |
| Disease | Astigmatism | 9.03e-04 | 129 | 254 | 6 | HP_0000483 | |
| Disease | neutrophil count | DENND4A HIVEP1 LSG1 SEPTIN9 MAML1 CTTNBP2NL MEF2D OTUD7B HOXA3 PTPRA SALL1 BEND7 RPRD2 NOTCH2 PCDHA7 CREBBP ADGRG6 TGFA HIVEP3 SPPL2A RP1L1 R3HDM1 SLC4A4 ZNF292 | 9.23e-04 | 1382 | 254 | 24 | EFO_0004833 |
| Disease | Glioma | 9.45e-04 | 87 | 254 | 5 | C0017638 | |
| Disease | Renal glomerular disease | 9.83e-04 | 23 | 254 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 9.83e-04 | 23 | 254 | 3 | C4521256 | |
| Disease | urate measurement, bone density | QRICH1 ERBIN SALL1 MAST4 GSE1 DMBT1 SYNE1 GRIN2C CCER1 LATS2 CLEC17A MAML2 CABIN1 ERCC6L2-AS1 | 1.03e-03 | 619 | 254 | 14 | EFO_0003923, EFO_0004531 |
| Disease | scoliosis | 1.08e-03 | 6 | 254 | 2 | EFO_0004273 | |
| Disease | diabetic angiopathy (implicated_via_orthology) | 1.08e-03 | 6 | 254 | 2 | DOID:11713 (implicated_via_orthology) | |
| Disease | Hepatoblastoma | 1.08e-03 | 6 | 254 | 2 | C0206624 | |
| Disease | Abnormal muscle tone | 1.08e-03 | 6 | 254 | 2 | C0852413 | |
| Disease | acute lymphoblastic leukemia (implicated_via_orthology) | 1.08e-03 | 6 | 254 | 2 | DOID:9952 (implicated_via_orthology) | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.12e-03 | 24 | 254 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.12e-03 | 24 | 254 | 3 | C3805278 | |
| Disease | Carcinoma, Pancreatic Ductal | 1.12e-03 | 24 | 254 | 3 | C0887833 | |
| Disease | Lynch syndrome (is_implicated_in) | 1.12e-03 | 24 | 254 | 3 | DOID:3883 (is_implicated_in) | |
| Disease | soluble triggering receptor expressed on myeloid cells 2 measurement | 1.13e-03 | 296 | 254 | 9 | EFO_0010151 | |
| Disease | Small cell carcinoma of lung | 1.21e-03 | 54 | 254 | 4 | C0149925 | |
| Disease | Metastatic melanoma | 1.21e-03 | 54 | 254 | 4 | C0278883 | |
| Disease | Cerebral Astrocytoma | 1.26e-03 | 25 | 254 | 3 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.26e-03 | 25 | 254 | 3 | C0750936 | |
| Disease | Astrocytoma | 1.26e-03 | 25 | 254 | 3 | C0004114 | |
| Disease | Grade I Astrocytoma | 1.26e-03 | 25 | 254 | 3 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.26e-03 | 25 | 254 | 3 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.26e-03 | 25 | 254 | 3 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 1.26e-03 | 25 | 254 | 3 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.26e-03 | 25 | 254 | 3 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.26e-03 | 25 | 254 | 3 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 1.26e-03 | 25 | 254 | 3 | C0338070 | |
| Disease | Bladder Neoplasm | 1.38e-03 | 140 | 254 | 6 | C0005695 | |
| Disease | Squamous cell carcinoma of esophagus | 1.40e-03 | 95 | 254 | 5 | C0279626 | |
| Disease | Cholangiocarcinoma | 1.42e-03 | 26 | 254 | 3 | C0206698 | |
| Disease | brain cancer (implicated_via_orthology) | 1.42e-03 | 26 | 254 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | Gemistocytic astrocytoma | 1.42e-03 | 26 | 254 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.42e-03 | 26 | 254 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.42e-03 | 26 | 254 | 3 | C0334582 | |
| Disease | Malignant neoplasm of urinary bladder | 1.43e-03 | 141 | 254 | 6 | C0005684 | |
| Disease | forced expiratory volume | NCOA6 SEPTIN9 HOXA3 ACAN ADAMTS17 RPRD2 TAL1 BMP2K SYNE1 RBM20 ADGRG6 NCOR2 PTPDC1 SH3PXD2A PPP6R2 GAB1 | 1.44e-03 | 789 | 254 | 16 | EFO_0004314 |
| Disease | Cerebellar Diseases | 1.51e-03 | 7 | 254 | 2 | C0007760 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 1.51e-03 | 7 | 254 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | Dental enamel hypoplasia, dental caries, tooth agenesis | 1.51e-03 | 7 | 254 | 2 | EFO_0003819, EFO_0005410, EFO_1001304 | |
| Disease | central nervous system cancer (implicated_via_orthology) | 1.51e-03 | 7 | 254 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | prostate carcinoma, breast carcinoma, ovarian carcinoma | 1.58e-03 | 27 | 254 | 3 | EFO_0000305, EFO_0001075, EFO_0001663 | |
| Disease | Sezary Syndrome | 1.58e-03 | 27 | 254 | 3 | C0036920 | |
| Disease | Anaplastic astrocytoma | 1.58e-03 | 27 | 254 | 3 | C0334579 | |
| Disease | susceptibility to rheumatic fever measurement | 1.76e-03 | 28 | 254 | 3 | EFO_0008416 | |
| Disease | triacylglycerol 58:6 measurement | 2.00e-03 | 8 | 254 | 2 | EFO_0010440 | |
| Disease | allantoin measurement | 2.00e-03 | 8 | 254 | 2 | EFO_0010456 | |
| Disease | Mammary Carcinoma, Human | RB1CC1 ZEB2 ZC3H11A TOX3 NOTCH2 NOTCH3 FN1 SYNE1 SLC5A5 KMT2D LBX1 HEY1 | 2.13e-03 | 525 | 254 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | RB1CC1 ZEB2 ZC3H11A TOX3 NOTCH2 NOTCH3 FN1 SYNE1 SLC5A5 KMT2D LBX1 HEY1 | 2.13e-03 | 525 | 254 | 12 | C1257931 |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.15e-03 | 63 | 254 | 4 | DOID:0050866 (is_marker_for) | |
| Disease | colorectal cancer (implicated_via_orthology) | 2.16e-03 | 30 | 254 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | Breast Cancer, Familial | 2.16e-03 | 30 | 254 | 3 | C0346153 | |
| Disease | Mammary Neoplasms | RB1CC1 ZEB2 ZC3H11A TOX3 NOTCH2 NOTCH3 FN1 SYNE1 SLC5A5 KMT2D LBX1 HEY1 | 2.20e-03 | 527 | 254 | 12 | C1458155 |
| Disease | neuroticism measurement | RPP21 HIVEP1 QRICH1 TOX3 KMT2A TAL1 NOS1 LMTK2 NCOR2 TENM3 FARP1 RP1L1 IGSF9B EIF4G3 MBD5 ERCC6L2-AS1 EPHA4 | 2.42e-03 | 909 | 254 | 17 | EFO_0007660 |
| Disease | neuroimaging measurement | EFS MAPK8IP3 OTUD7B NEO1 MAST4 TOX3 WNK2 MRC1 MCPH1 APC ACTRT2 PTPN21 KCTD17 CCDC88C COL18A1 SH3PXD2A KIF18B PCDH7 EPHA4 | 2.42e-03 | 1069 | 254 | 19 | EFO_0004346 |
| Disease | breast carcinoma (is_marker_for) | 2.54e-03 | 66 | 254 | 4 | DOID:3459 (is_marker_for) | |
| Disease | Lynch Syndrome | 2.55e-03 | 9 | 254 | 2 | C4552100 | |
| Disease | plexin-B2 measurement | 2.55e-03 | 9 | 254 | 2 | EFO_0021867 | |
| Disease | Breast Carcinoma | RB1CC1 ZEB2 ZC3H11A TOX3 NOTCH2 NOTCH3 FN1 SYNE1 SLC5A5 KMT2D LBX1 HEY1 | 2.60e-03 | 538 | 254 | 12 | C0678222 |
| Disease | hearing loss | 2.69e-03 | 67 | 254 | 4 | EFO_0004238 | |
| Disease | Glioblastoma Multiforme | 2.78e-03 | 111 | 254 | 5 | C1621958 | |
| Disease | large artery stroke | 3.00e-03 | 113 | 254 | 5 | EFO_0005524 | |
| Disease | body weight | HIVEP1 HLF E2F7 GON4L OTUD7B MAST4 GSE1 ACAN ADAMTS17 DMD TAL1 TBX4 C16orf82 TOM1L1 NOX4 PHC2 ADGRG6 USF3 PCDH7 ERCC6L2-AS1 EPHA4 | 3.14e-03 | 1261 | 254 | 21 | EFO_0004338 |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 3.17e-03 | 10 | 254 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | Abnormality of nervous system morphology | 3.17e-03 | 10 | 254 | 2 | C4022810 | |
| Disease | Inflammatory Bowel Diseases | 3.37e-03 | 35 | 254 | 3 | C0021390 | |
| Disease | coronary artery disease | NCOA6 NAB1 QRICH1 ZNF831 ZEB2 MAPK8IP3 HIRA OTUD7B ZC3H11A MAST4 SIK2 RPRD2 PSRC1 WNK2 FN1 ACTRT2 PKD1L3 FARP1 CABIN1 SMAD2 | 3.67e-03 | 1194 | 254 | 20 | EFO_0001645 |
| Disease | Leukemia, Myelocytic, Acute | 3.96e-03 | 173 | 254 | 6 | C0023467 | |
| Disease | Hereditary Diffuse Gastric Cancer | 4.05e-03 | 293 | 254 | 8 | C1708349 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 4.16e-03 | 122 | 254 | 5 | EFO_0004318, EFO_0007789 | |
| Disease | Stomach Neoplasms | 4.40e-03 | 297 | 254 | 8 | C0038356 | |
| Disease | bipolar disorder | RPS6KA2 RBPJL HLF OTUD7B CDAN1 WNK2 SYNE1 TMEM63C SYBU ARHGEF15 KMT2D IGSF9B | 4.54e-03 | 577 | 254 | 12 | MONDO_0004985 |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 4.60e-03 | 12 | 254 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | Cachexia | 4.60e-03 | 12 | 254 | 2 | C0006625 | |
| Disease | cholesteryl ester 24:5 measurement | 4.60e-03 | 12 | 254 | 2 | EFO_0021448 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPSSPLSAEQLDRIQ | 61 | P13051 | |
| LSIQALLSAPNPDDP | 106 | P61088 | |
| TQSLNPAPFSPLTAQ | 1446 | P55196 | |
| NAPSRLNQSPSLAPV | 701 | Q9H2P0 | |
| SPPSRDLSPTLIDNS | 481 | Q9P2B4 | |
| PPQLLPRSESTENQS | 1006 | Q96RT1 | |
| PPLELQSSNQSQLFP | 6 | P46663 | |
| ISLPLSARNSQPHSP | 296 | Q4VCS5 | |
| PNREPVQALPSSASR | 196 | Q9HB65 | |
| LQSPSQTFCLPQTPE | 296 | A6NCI8 | |
| SPTNLLTLSPAPSQE | 341 | A6NCI8 | |
| DPLPNPSLTARSSQA | 121 | P26842 | |
| SPADQLLIAPANSPL | 131 | Q00973 | |
| KPSDQPLLATEPSLN | 101 | Q8TDY3 | |
| PPNLLENLSPEDSVL | 726 | Q86SQ4 | |
| SISNLERPSSPPSIQ | 676 | Q12774 | |
| ATQPAALPTLLPSQS | 611 | Q9HCU0 | |
| ALPTLLPSQSPTNQT | 616 | Q9HCU0 | |
| PPAAAQLTLNANPLD | 26 | Q6UY09 | |
| RTTATVNPLTPSPLN | 21 | Q14687 | |
| SPSSVVQDSRFPPLN | 186 | Q14687 | |
| SVSAQNSDTPLLPPA | 331 | Q96DB2 | |
| SPSPVSLSNPAQVDL | 651 | Q9Y3L3 | |
| PLASSLNSDVPQQRP | 1451 | Q68CP9 | |
| QPPNLISESALPTSL | 541 | Q92793 | |
| VQPPRSISPSALQDL | 2056 | Q92793 | |
| TPPSSPTLLDALLQN | 21 | Q8NDD1 | |
| PEPLLSKNLSSISNP | 61 | Q96M93 | |
| SSPQELPRNSNDAPT | 41 | O94989 | |
| PTSTEPRQQPSALFA | 146 | Q6IQ19 | |
| QDSPLSQPRSPAQIL | 3481 | P11532 | |
| LQEAAQRPSPPSALT | 266 | Q8TF21 | |
| NNLLSAPPPDVTQLT | 721 | O75179 | |
| VTQLTPPSHDLNRAP | 731 | O75179 | |
| SNINNSSIPSALPEP | 326 | Q9NSY1 | |
| TNIRLPNVPSSSLPA | 181 | Q96CF2 | |
| FSPNPEENQSLAPLL | 261 | Q8TC90 | |
| RPSLTLSDPPNLSNL | 161 | Q8IWY9 | |
| NQLLSTPLPEPDLTR | 556 | Q2TB18 | |
| LSLSNQVEQPDDRPP | 826 | Q8TE58 | |
| LTPSPSAEAQRPEQL | 186 | Q8TE56 | |
| PSTPLEVPLNASSTN | 1136 | O95450 | |
| EARLDPPTQQPISNT | 191 | P56880 | |
| PQLSLSSPNPSDIRV | 531 | Q8TDY8 | |
| TPQHPQPLSLDSREA | 191 | Q5JR59 | |
| SPHDNLILSQPVSSP | 371 | Q7Z401 | |
| IISPAQSPAPAQLST | 886 | Q15032 | |
| LLANIDPNPDAVSPT | 356 | Q9HBD1 | |
| FVRSNNVPESSLPPA | 636 | Q9HBD1 | |
| SQPLPVSISNASCLP | 1141 | Q9HBD1 | |
| HLNREISLPSEPPNS | 231 | Q9H4I0 | |
| VPPNPLTHLSLQDRS | 11 | Q9UBG7 | |
| VSNPNPLLPSPASLQ | 76 | Q5T481 | |
| RLQATLSLPFAPSPQ | 286 | Q7Z3H0 | |
| NPSLTPDFSLTQDRP | 91 | Q8NBR0 | |
| PQQDSLLVSLPSATP | 711 | Q7Z6P3 | |
| IQTPSLQSPSPSQLQ | 151 | Q2TAL8 | |
| PLARDQPSSVPASQS | 201 | Q9H0J4 | |
| SLSQEDAPQTPRPVA | 56 | P04090 | |
| RQLEALLSSLPPPQS | 191 | Q9H607 | |
| LLSSLPPPQSQKEAQ | 196 | Q9H607 | |
| TDLLLTFNQPPPDNR | 136 | Q9HD47 | |
| RNPLSSSDAAPSPEL | 101 | O00763 | |
| PSQPLPDLADHLSAQ | 56 | Q8N9V6 | |
| NAPQLTLTSLSLPIP | 346 | Q9UN72 | |
| LSSDAQAPLAQPESP | 436 | Q6GQQ9 | |
| EDTSQAQELPNLPSP | 131 | Q9NZ53 | |
| IEENLSSPNPISDPQ | 741 | Q8TDY2 | |
| SLLPPVSAQQRTSAP | 901 | Q92585 | |
| LPESQPSSSPLLQTA | 2106 | Q9Y618 | |
| TNIQLVSISRPDPPS | 931 | O60500 | |
| RTPSLALTPPQAEQE | 1801 | Q04721 | |
| LPQPNVNQSSRPLSE | 1471 | Q8NEZ4 | |
| PELQPSTSRNQLVTP | 1576 | Q14676 | |
| EDSLSPLQIPQSPLE | 686 | O60732 | |
| SPLAQQSPLAQPSPA | 1031 | Q86UL8 | |
| NSESPEIPLNPILAF | 711 | Q14244 | |
| PESQLPSSPAQLSCR | 431 | Q8NEM0 | |
| PSAAVTPLNESLQPL | 281 | Q9UPT6 | |
| LPARDSPSLSENPTT | 286 | Q9H089 | |
| TPANAAKSPLLNSPT | 136 | O43365 | |
| ISDVAPSASNNSPPL | 226 | Q86T24 | |
| TSSVQPLPLPNDCAT | 121 | Q9UKR0 | |
| QVFASDSPPQSLLTP | 336 | Q9NRM7 | |
| DSPPQSLLTPSRNSL | 341 | Q9NRM7 | |
| LFNQPLTSLPVSSIP | 81 | Q13506 | |
| PTTLNLFPQVPRSQD | 161 | Q9UQF2 | |
| NLDSLVTRPAPPAQS | 521 | O95208 | |
| ADLPLAINTAPPSTQ | 136 | Q13480 | |
| LSNISSARPQPLSPV | 1176 | Q5HYC2 | |
| DPASPAASQPLRSQA | 1441 | Q9P219 | |
| TRPPSAPLNLISNVN | 326 | P54764 | |
| VLQEPELNLTPASSP | 746 | Q9P1W3 | |
| SQPPSQPEDLSLAVL | 496 | Q9H307 | |
| INDNTPTFPSPVLTL | 136 | O60245 | |
| LLTEPLSREHPPQSQ | 751 | Q9H5P4 | |
| LSPAAAAPSQQLQRP | 241 | P39060 | |
| ALSILSQEAPPQRPS | 71 | A0A1B0GUS0 | |
| TNRSQEELSPSPPLL | 301 | Q8N5Y2 | |
| PLPLSVPSSLAQAQT | 2291 | Q9UM47 | |
| TPPQSPLNIDTLSSC | 1301 | Q8TDM6 | |
| LPPSNITSSQEPALL | 661 | Q96LU7 | |
| ASSSVQDFSRPPPQL | 1536 | Q8WWI1 | |
| LRNPPNPSESLSSNS | 1926 | Q8NEV8 | |
| FTLSVPNISLPAPSQ | 106 | Q8IWU2 | |
| VLANPPNISSLSPRQ | 51 | Q13421 | |
| QDSFTPVVNSLDPPL | 2306 | P00451 | |
| PPPSQSDQLLAESSS | 161 | Q99988 | |
| PASQSTENRVLPAPA | 91 | Q7L590 | |
| LLRHDSDVSNPPNPT | 336 | A2A3K4 | |
| PIRSVLAPQPSTSNS | 246 | Q6PGN9 | |
| NIPESLPPSRRNSNS | 371 | Q96P66 | |
| ANRNTPSPIDPDTIQ | 156 | Q16534 | |
| SALTSNRPEPIPDQQ | 371 | Q7Z3K6 | |
| NLAISLDNQSSPSPP | 971 | Q2PPJ7 | |
| TCSRPISPLLDQNTP | 906 | Q15375 | |
| ALQPDPAPLSAALQS | 176 | Q96T92 | |
| QNPTHALPESPRLTL | 471 | Q86Y91 | |
| QSSQDPANLFSLPPL | 246 | Q8N5Z5 | |
| LPPSSQDSEILPFIQ | 386 | Q9NPH5 | |
| DNSLSVSIPQPSPLR | 26 | P16112 | |
| SRPAPLVQQLSPSLL | 686 | Q9Y6X9 | |
| TTPPTPLQLQQFASL | 1106 | P29475 | |
| TNSTSDPQSPNPPLL | 1091 | Q16825 | |
| ASPPFPLISNAQDLA | 176 | Q8N3R9 | |
| PSSQPAQSLPSQPLL | 666 | Q8IZL2 | |
| NNRPPSTEPSEISLS | 1226 | Q14686 | |
| SHPELLPSIAPSQNL | 1956 | Q14686 | |
| LPDSSSPVPANNIRV | 711 | Q9BWT3 | |
| TRNLSQPESPVLLPA | 56 | Q5TZA2 | |
| ELSISARQQPTPLTP | 1801 | Q9Y6J0 | |
| ADLPQLESSLQPVSP | 531 | Q9BXL6 | |
| SSTLPSADPQLQSQP | 806 | Q96AV8 | |
| RSPPSNLALASETPD | 741 | Q9P218 | |
| VAPANVTLSPNLSPD | 491 | Q9Y4F1 | |
| NLSPDTKQASPLISP | 501 | Q9Y4F1 | |
| VTPLSPPTNLHLEAN | 1171 | P02751 | |
| NITLSDVNDNPPRFP | 261 | Q9HBT6 | |
| TPLVLPSNIQSARPS | 461 | Q9P2H0 | |
| SLNPRPQTTISPADL | 536 | Q96JB2 | |
| RLLTPANSNPVLENP | 91 | Q8WZB0 | |
| TRPPSAPVNLISSVN | 326 | P29322 | |
| PPSPDTAQLALELHQ | 661 | Q6P2H3 | |
| REDLTSTLPSSQPPQ | 76 | Q6PIV2 | |
| PPVDSLDSGNNPRLQ | 511 | Q5VWK5 | |
| PPNTSSTESLKPLAN | 186 | Q6K0P9 | |
| PCPLNQSLVASSVSP | 1191 | Q3T8J9 | |
| ALESDNPSQPETSLP | 251 | Q5T0F9 | |
| PDASPQQLVSTFRLP | 1521 | Q9BZC7 | |
| TVSLNPRPLNSLPEL | 116 | Q5SVJ3 | |
| DQDTLAQLLARSPPP | 276 | O43281 | |
| PESTPIPANLSQNLE | 486 | Q04637 | |
| TQLDPDLPRPESSTQ | 51 | Q12967 | |
| SPAPNTDRPISLSNE | 2586 | O15021 | |
| PSLLSSLPISLPVNQ | 916 | Q9P267 | |
| PPDPQLLVSESSQRT | 3191 | Q03164 | |
| PNALSPSAPTQAANL | 276 | Q9Y5J3 | |
| PPRLNSSAEAPQSLH | 96 | Q8N7W2 | |
| ASSLQQPSNLDLPPA | 196 | Q86UT8 | |
| QLSPASPLTDQPASS | 251 | P52954 | |
| PSPQRAFTLQVSSDP | 686 | P54198 | |
| STPAPFLNITRPNTD | 1991 | Q9UGM3 | |
| FRPPPANASLQDILS | 86 | Q9Y226 | |
| LSLQSSPQPESLRPV | 511 | O95487 | |
| SLSPSPALALPNLAN | 436 | Q5VT52 | |
| SSLLSPASNPLLPQQ | 381 | Q9NSC2 | |
| LLPQQASANSVFPSP | 391 | Q9NSC2 | |
| NPQPPDLSAVTLSRE | 2856 | P21817 | |
| SSLNRFSALQPPAPS | 1096 | O43432 | |
| VSPAQARPETFPNSL | 246 | Q96JN8 | |
| PASFQNLRPEPASLQ | 36 | Q9BWJ2 | |
| SSTPLCQLPQEEPLT | 836 | Q8TE73 | |
| RSLETPQPAASLPDN | 426 | O75170 | |
| SSLTDPRLLSPQQPA | 171 | Q14814 | |
| LSNATAQSPLPILSP | 1011 | Q13029 | |
| LTPLQSPAQVLPNSS | 1601 | Q12923 | |
| EPQSVPLLARSPSTN | 201 | P18433 | |
| NDNPPELTLSSVNSP | 341 | Q9Y5E6 | |
| PQDPHLPLSSLVSIN | 491 | Q9Y5E3 | |
| TRSDPSLTNPPATIQ | 1081 | P22897 | |
| SPLLPQQARSLDPQS | 236 | Q15406 | |
| TLTNELPPTSPTCLQ | 196 | Q96J94 | |
| LPSDQPAEPNFSTLL | 106 | Q96JB3 | |
| SSSPSPLAPARQDLA | 91 | Q5TD94 | |
| RPLTQQTLTSQPDPS | 231 | Q9BQG1 | |
| LPVSRRENNSPSNLP | 141 | Q9UN30 | |
| SASPSRALPEPQEAQ | 476 | Q2YD98 | |
| SAPSQDLLDLSPSPR | 311 | O75674 | |
| EPLLNSPDPLLSSFS | 541 | Q3MII6 | |
| PQPSSNLSLSLAQPL | 8251 | Q8NF91 | |
| SLVVPLPNTSESFQP | 326 | Q86VY9 | |
| PIRQAFDQPADTSPL | 401 | Q7Z3H4 | |
| SSSILPTQDPNLKPT | 2016 | A0AVI2 | |
| SLSQEDAPQTPRPVA | 56 | P04808 | |
| ENRPFSPSPLNNISS | 1231 | Q5UIP0 | |
| PPDDLLQDVLSPNSS | 276 | P17542 | |
| SLPQLPRELPSSHTN | 561 | Q9NYY8 | |
| QDSPLLATLPLQASP | 521 | Q9H6K5 | |
| LETQSSLAPPSLQTP | 711 | Q9H6K5 | |
| QTASAPLTTPPLENL | 746 | Q9H6K5 | |
| LPQESLTSILPENFP | 576 | Q8IWB4 | |
| LPENPPNFLRASALS | 291 | O00291 | |
| DPALPSTPLLSQQAL | 1376 | Q92859 | |
| ASEPSSQPLPVITQL | 221 | Q7Z443 | |
| SEPAPVSQLQSRLEP | 211 | Q9UHD8 | |
| PLQPLPNTAHSISDR | 126 | Q9H633 | |
| PSQQAPPFSLTQPLS | 761 | Q9H0K1 | |
| NRELPLTQPPSAHSS | 411 | Q9HCD6 | |
| QPEQLVSSAPTLSAP | 256 | Q9H9Q4 | |
| QELLATSAAEQPPSP | 811 | O95785 | |
| ETTSRQPAFQALPAP | 61 | Q8NHX4 | |
| SVSQPPLIATNTNLP | 871 | Q15714 | |
| SLADSISINLPAPPN | 1101 | Q8TAQ2 | |
| LQSQSPVQLPSPACT | 1646 | Q9H2D6 | |
| RLPPQLAQLSSPCSS | 606 | Q8WZ75 | |
| SAPDPPVLRETAQNT | 146 | Q8IY92 | |
| QEPSQSPPRSEAVLQ | 1201 | Q8IY92 | |
| PNQSSNERPPSLLVI | 171 | O15042 | |
| PVARSSPQHSLSNPL | 106 | Q86UE8 | |
| NPILLNSSIPEDPSI | 306 | P21589 | |
| RSQAQTPVLSPSLPD | 2476 | P25054 | |
| QLSLQREQAPSPPAA | 521 | Q9UPV0 | |
| PTLQTLANAPASSPL | 776 | Q9BPX3 | |
| VNLEPSPLQPSLAAT | 136 | Q6ZS10 | |
| NLLTTCSTPLLNSPP | 106 | Q9Y679 | |
| LPASAQPRPQSTSLL | 271 | Q96EP0 | |
| PNLQAQEAPAPVTTS | 386 | Q15735 | |
| LPQESLTSILPENFP | 576 | Q5VYP0 | |
| PRSLSFPILNPALSQ | 481 | Q8ND24 | |
| QALENSTSPLSADPP | 21 | P01135 | |
| NSSPEPQALTPSSKL | 716 | P98169 | |
| PQLASVSPSVALQPS | 376 | Q8IXK0 | |
| SFQSLNPVLSLPINP | 871 | Q86Y38 | |
| DSSPSPFQPLRNLTI | 496 | O15455 | |
| QQPSTELSTPTDPRL | 731 | P61129 | |
| NLDPSQAPSLAQPLV | 301 | Q14157 | |
| LPARPSSDIPLDNSS | 296 | Q9C0A1 | |
| LPQESLTSILPENFP | 576 | Q5TZJ5 | |
| ARDTPQPSSPLVLQV | 796 | Q8IWN7 | |
| LPQESLTSILPENFP | 576 | Q5VU36 | |
| PALLPANDSSRAPSS | 496 | Q92911 | |
| LQPSRLSPLTQSPLS | 1196 | Q9UPX0 | |
| RNPNSAILLSPVETP | 546 | Q9NX95 | |
| PTTLSPVNHSLDLQP | 251 | Q15796 | |
| SDSPLLPAQRNSIPV | 1041 | Q5TCZ1 | |
| NPRDSLVLPPTQSSS | 721 | O75152 | |
| NLTSTPLCNLSDIPP | 66 | Q8TCT8 | |
| SAPRSEPVINNDNPL | 346 | P23497 | |
| NPEILPSSLPSQAAE | 186 | Q6GPH4 | |
| TTLPSQDASLPPQQP | 716 | O14964 | |
| RITPNFPNTLDPAIS | 46 | Q9P1D8 | |
| PPLIAPNASQNLVTS | 1636 | O60281 | |
| LSQSSTAQSLEDPPP | 326 | Q5T1R4 | |
| NDRPVTANTTSLPPA | 196 | Q9HCK1 | |
| PDPQDIISQSLQSPS | 816 | Q9P273 | |
| SQRTSQLDPPALQAP | 296 | Q9BRR9 | |
| SATRTPALIPVDPQN | 2091 | Q68DE3 | |
| SPQTLQQSLPRSIAP | 371 | O15405 | |
| VLTTLPLPSANSPVN | 186 | O95473 | |
| RNFPLILESPSPNQT | 91 | A0A0K0K1C4 | |
| SDSSVDPQQPFNPLL | 76 | Q8N357 | |
| LQSLIPFVQLPPSDS | 236 | P54278 | |
| ENPRDSLVLPPTQSS | 721 | A0A1B0GTU1 | |
| QFAEDPSQLPSTQLP | 146 | Q99595 | |
| THSSLLDLIPENPNP | 801 | Q6ZT12 | |
| QPRPQDSNLSLTVPA | 941 | Q9UPP1 | |
| PPDPANISISNDTTL | 631 | Q9Y6R1 | |
| SQLAEPQDLPLSTFP | 311 | P57082 | |
| PQDLPLSTFPTQRDS | 316 | P57082 | |
| QSVPTQTATLLPPAN | 1081 | Q9Y3S1 | |
| TAPFPVSQNSLPALE | 661 | P48553 | |
| SNIALSPTLPQSLAP | 301 | Q9BWQ6 | |
| TPPQAPRVLSALADN | 921 | Q5JPB2 | |
| PSLERSSKPLAPNSN | 706 | O60315 | |
| PQRSPLQSAESSPTA | 791 | Q8IWB9 | |
| DQSPLQSPSNLRDNP | 931 | Q9HAU0 | |
| QPPLSDDLQPSSAVS | 321 | Q9C0B0 | |
| AALQALQAQAPTSPP | 471 | Q8NAF0 | |
| EPSLQSPSLELQSPA | 91 | Q7Z2V1 | |
| ASPQHLPSRSSLQDP | 2211 | P15822 | |
| TFAPLLSDNVPQTPE | 1106 | Q63HR2 | |
| VSRLASPLPPQEASN | 1126 | Q8NFA0 | |
| PESLLNSQSPESKPQ | 766 | Q14202 | |
| LPSLPSNSSQERPLD | 16 | P30518 | |
| SQLPSPSSQLPTEAQ | 4321 | O14686 | |
| LLAALPTPPHNQTED | 4676 | O14686 | |
| PQAPRLEPVLSSNLA | 706 | Q15349 | |
| QSLASPPRQASPDLT | 871 | Q14957 | |
| PPRQASPDLTASSAQ | 876 | Q14957 |